Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
CTNNB1	Missense_Mutation	p.W383C	G	G		1	Investigate Actionability	3	41274899	41274899	374	0.0347593582887701	NA	NA	NA		p.W383C(1)	3893		Some prognostic effects in colon cancer and gastric cancer.  Activation may mediate resistance to EGFR TKIs, PI3K inhibitors, and AKT inhibitors. Activation may predict sensitivity to inhibitors of WNT signaling	MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,41274899,G,G&fts=all">p.W383C</a>
ALK	Missense_Mutation	p.E314K	C	C	rs538448899	2	High Priority	2	29917728	29917728	195	0.364102564102564	NA	NA	NA			340	MAM 1. {ECO:0000255|PROSITE- ProRule:PRU00128}.	Translocations predict sensitivity to ALK-inhibitors such as crizotinib.  Secondary mutations can cause resistance.  Amplification and activating mutations may also be sensitive to these agents.	MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,29917728,C,C&fts=all">p.E314K</a>
ETV4	Missense_Mutation	p.R148W	G	G	rs144213199	2	High Priority	17	41610249	41610249	217	0.0414746543778802	NA	NA	NA			3	Gln-rich.	Diagnostic in prostate cancer	MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETV4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41610249,G,G&fts=all">p.R148W</a>
FLT3	Missense_Mutation	p.E204K	C	C		2	High Priority	13	28626686	28626686	166	0.307228915662651	NA	NA	NA			12390		Mutations predict sensitivity to FLT3 inhibitors, sunitinib.  Secondary mutations predict resistance.	MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28626686,C,C&fts=all">p.E204K</a>
PDGFRA	Missense_Mutation	p.G430E	G	G	rs202072966	2	High Priority	4	55138612	55138612	226	0.420353982300885	NA	NA	NA			967	Ig-like C2-type 5.	Alterations may predict sensitivity to imatinib and other TKIs	MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,55138612,G,G&fts=all">p.G430E</a>
CSF1R	Missense_Mutation	p.G64S	C	C		3.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	5	149460447	149460447	96	0.364583333333333	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		93	Ig-like C2-type 1.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149460447,C,C&fts=all">p.G64S</a>
RUNX1T1	Missense_Mutation	p.E250K	C	C		3.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	8	93004110	93004110	252	0.404761904761905	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		86			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,93004110,C,C&fts=all">p.E250K</a>
BCL11A	Missense_Mutation	p.R68W	G	G		4	Cancer Gene Census	2	60773289	60773289	174	0.028735632183908	NA	NA	NA			59	Required for nuclear body formation and for SUMO1 recruitment. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,60773289,G,G&fts=all">p.R68W</a>
BCL9	Missense_Mutation	p.K94R	A	A		4	Cancer Gene Census	1	147084909	147084909	134	0.276119402985075	NA	NA	NA			7			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,147084909,A,A&fts=all">p.K94R</a>
IL7R	Missense_Mutation	p.S420F	C	C		4	Cancer Gene Census	5	35876467	35876467	94	0.404255319148936	NA	NA	NA			126			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL7R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35876467,C,C&fts=all">p.S420F</a>
KDSR	Missense_Mutation	p.S20F	G	G		4	Cancer Gene Census	18	61034293	61034293	56	0.392857142857143	NA	NA	NA			9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDSR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,61034293,G,G&fts=all">p.S20F</a>
MLLT1	Missense_Mutation	p.T6I	G	G		4	Cancer Gene Census	19	6270766	6270766	61	0.213114754098361	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,6270766,G,G&fts=all">p.T6I</a>
NIN	Missense_Mutation	p.H229Y	G	G		4	Cancer Gene Census	14	51239795	51239795	129	0.356589147286822	NA	NA	NA			71	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,51239795,G,G&fts=all">p.H229Y</a>
PPP2R1A	Missense_Mutation	p.R171W	C	C		4	Cancer Gene Census	19	52715946	52715946	86	0.441860465116279	NA	NA	NA			135	PP2A subunit B binding.|Polyoma small and medium T antigens Binding.|SV40 small T antigen binding.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52715946,C,C&fts=all">p.R171W</a>
TRIM33	Missense_Mutation	p.P810S	G	G		4	Cancer Gene Census	1	114948372	114948372	174	0.402298850574713	NA	NA	NA			48			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114948372,G,G&fts=all">p.P810S</a>
ZNF331	Missense_Mutation	p.E380K	G	G		4	Cancer Gene Census	19	54080952	54080952	159	0.471698113207547	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF331&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54080952,G,G&fts=all">p.E380K</a>
IGF1	Missense_Mutation	p.S101L	G	G		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	12	102813339	102813339	109	0.403669724770642	NA	NA	NA	 BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_LONGEVITY_PATHWAY  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		11	A.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,102813339,G,G&fts=all">p.S101L</a>
ITGA2B	Missense_Mutation	p.L583F	G	G		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	17	42457375	42457375	70	0.285714285714286	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42457375,G,G&fts=all">p.L583F</a>
LAMA3	Missense_Mutation	p.G3042R	G	G		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	18	21523849	21523849	155	0.393548387096774	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	Laminin G-like 4. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21523849,G,G&fts=all">p.G3042R</a>
LAMA3	Missense_Mutation	p.G3092R	G	G		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	18	21526171	21526171	244	0.372950819672131	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	Laminin G-like 4. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21526171,G,G&fts=all">p.G3092R</a>
LAMA4	Missense_Mutation	p.E159K	C	C	rs540626879	4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	6	112522837	112522837	611	0.0114566284779051	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		100	Laminin EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,112522837,C,C&fts=all">p.E159K</a>
NKX3-1	Missense_Mutation	p.S132F	G	G		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	8	23539044	23539044	282	0.436170212765957	NA	NA	NA	 KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKX3-1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23539044,G,G&fts=all">p.S132F</a>
PIAS4	Missense_Mutation	p.H218Y	C	C		4.16666666666667	Cancer Pathway Linked to: CTNNB1; PDGFRA; FLT3	19	4028578	4028578	76	0.210526315789474	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		17	PINIT. {ECO:0000255|PROSITE- ProRule:PRU00799}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIAS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4028578,C,C&fts=all">p.H218Y</a>
BAD	Missense_Mutation	p.R39C	G	G		4.5	Cancer Pathway Linked to: CTNNB1	11	64051726	64051726	129	0.37984496124031	NA	NA	NA	 BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		4			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64051726,G,G&fts=all">p.R39C</a>
HFM1	Missense_Mutation	p.S762L	G	G		5	Cancer Pathway	1	91809037	91809037	113	0.380530973451327	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91809037,G,G&fts=all">p.S762L</a>
HFM1	Missense_Mutation	p.P529S	G	G		5	Cancer Pathway	1	91841095	91841095	197	0.345177664974619	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91841095,G,G&fts=all">p.P529S</a>
KLRK1	Missense_Mutation	p.R5C	G	G	rs544134653	5	Cancer Pathway	12	10541397	10541397	287	0.383275261324042	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10541397,G,G&fts=all">p.R5C</a>
MAP3K1	Missense_Mutation	p.T799I	C	C		5	Cancer Pathway	5	56177423	56177423	267	0.318352059925094	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  BIOCARTA_CD40_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  | 		57			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,56177423,C,C&fts=all">p.T799I</a>
PRKAR1B	Splice_Site	p.K59R	T	T		5	Cancer Pathway	7	750967	750967	147	0.319727891156463	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  | 		17	Dimerization and phosphorylation.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAR1B&recr=Open">Click here</a>	
SI	Missense_Mutation	p.P219S	G	G		6	Cancer Pathway	3	164783201	164783201	88	0.329545454545455	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Isomaltase.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164783201,G,G&fts=all">p.P219S</a>
ADCY7	Missense_Mutation	p.F736L	T	T		7	Cancer Module	16	50344643	50344643	155	0.354838709677419	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,50344643,T,T&fts=all">p.F736L</a>
AFP	Missense_Mutation	p.S30F	C	C		7	Cancer Module	4	74302880	74302880	158	0.335443037974684	NA	NA	NA			22	Albumin 1. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74302880,C,C&fts=all">p.S30F</a>
AKAP10	Missense_Mutation	p.S49F	G	G		7	Cancer Module	17	19866326	19866326	270	0.396296296296296	NA	NA	NA			21			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19866326,G,G&fts=all">p.S49F</a>
ALDH3A1	Missense_Mutation	p.P22L	G	G		7	Cancer Module	17	19648378	19648378	47	0.382978723404255	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19648378,G,G&fts=all">p.P22L</a>
ALOX12B	Missense_Mutation	p.G11S	C	C		7	Cancer Module	17	7990730	7990730	281	0.366548042704626	NA	NA	NA			16	PLAT. {ECO:0000255|PROSITE- ProRule:PRU00152}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7990730,C,C&fts=all">p.G11S</a>
AMMECR1	Missense_Mutation	p.R298C	G	G		7	Cancer Module	X	109441858	109441858	60	0.716666666666667	NA	NA	NA			7	AMMECR1. {ECO:0000255|PROSITE- ProRule:PRU00467}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMMECR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,109441858,G,G&fts=all">p.R298C</a>
ANGPTL4	Missense_Mutation	p.D281N	G	G		7	Cancer Module	19	8436208	8436208	71	0.183098591549296	NA	NA	NA			6	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8436208,G,G&fts=all">p.D281N</a>
ANK2	Missense_Mutation	p.E3621K	G	G		7	Cancer Module	4	114286266	114286266	338	0.396449704142012	NA	NA	NA			248	Death 2. {ECO:0000255|PROSITE- ProRule:PRU00064}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,114286266,G,G&fts=all">p.E3621K</a>
ANKRD11	Missense_Mutation	p.P1661S	G	G		7	Cancer Module	16	89347969	89347969	595	0.391596638655462	NA	NA	NA			83			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89347969,G,G&fts=all">p.P1661S</a>
ANKRD26	Missense_Mutation	p.V855I	C	C		7	Cancer Module	10	27326249	27326249	576	0.0104166666666667	NA	NA	NA			70			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,27326249,C,C&fts=all">p.V855I</a>
AOX1	Missense_Mutation	p.M1055I	G	G	rs149138495	7	Cancer Module	2	201521654	201521654	176	0.323863636363636	NA	NA	NA			81			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,201521654,G,G&fts=all">p.M1055I</a>
APOB	Missense_Mutation	p.V965A	A	A		7	Cancer Module	2	21242700	21242700	161	0.391304347826087	NA	NA	NA			305			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21242700,A,A&fts=all">p.V965A</a>
ARVCF	Missense_Mutation	p.R740W	G	G		7	Cancer Module	22	19961187	19961187	177	0.0225988700564972	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARVCF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19961187,G,G&fts=all">p.R740W</a>
ATN1	Missense_Mutation	p.G193R	G	G		7	Cancer Module	12	7045007	7045007	198	0.393939393939394	NA	NA	NA			40			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7045007,G,G&fts=all">p.G193R</a>
ATP2A3	Nonsense_Mutation	p.R836*	G	G		7	Cancer Module	17	3839579	3839579	137	0.0291970802919708	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3839579,G,G&fts=all">p.R836*</a>
ATP5A1	Missense_Mutation	p.S295F	G	G		7	Cancer Module	18	43667374	43667374	226	0.345132743362832	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,43667374,G,G&fts=all">p.S295F</a>
ATP8A1	Missense_Mutation	p.H944Y	G	G		7	Cancer Module	4	42454064	42454064	81	0.382716049382716	NA	NA	NA			51			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,42454064,G,G&fts=all">p.H944Y</a>
BIN1	Missense_Mutation	p.P585L	G	G		7	Cancer Module	2	127806130	127806130	250	0.4	NA	NA	NA			24	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,127806130,G,G&fts=all">p.P585L</a>
C2CD3	Missense_Mutation	p.P1069S	G	G		7	Cancer Module	11	73805000	73805000	293	0.348122866894198	NA	NA	NA			64			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2CD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,73805000,G,G&fts=all">p.P1069S</a>
CADM3	Missense_Mutation	p.R116Q	G	G		7	Cancer Module	1	159162383	159162383	197	0.243654822335025	NA	NA	NA			55	Ig-like V-type.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159162383,G,G&fts=all">p.R116Q</a>
CCDC106	Missense_Mutation	p.S73F	C	C		7	Cancer Module	19	56160855	56160855	93	0.56989247311828	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC106&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56160855,C,C&fts=all">p.S73F</a>
CCDC9	Splice_Site	p.M1T	T	T		7	Cancer Module	19	47761659	47761659	303	0.257425742574257	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC9&recr=Open">Click here</a>	
CD86	Splice_Site	p.G277E	G	G		7	Cancer Module	3	121836895	121836895	82	0.451219512195122	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	
CDH4	Missense_Mutation	p.P505S	C	C		7	Cancer Module	20	60498647	60498647	66	0.196969696969697	NA	NA	NA			74	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,60498647,C,C&fts=all">p.P505S</a>
CMKLR1	Missense_Mutation	p.H184N	G	G		7	Cancer Module	12	108686190	108686190	115	0.417391304347826	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMKLR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,108686190,G,G&fts=all">p.H184N</a>
CNTNAP2	Missense_Mutation	p.L837F	C	C		7	Cancer Module	7	147815335	147815335	134	0.328358208955224	NA	NA	NA			188	Laminin G-like 3. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,147815335,C,C&fts=all">p.L837F</a>
COL2A1	Missense_Mutation	p.G951E	C	C		7	Cancer Module	12	48372423	48372423	79	0.430379746835443	NA	NA	NA			64	Triple-helical region.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48372423,C,C&fts=all">p.G951E</a>
COL3A1	Nonsense_Mutation	p.R1109*	C	C	rs112371422	7	Cancer Module	2	189872295	189872295	81	0.345679012345679	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189872295,C,C&fts=all">p.R1109*</a>
COL6A3	Missense_Mutation	p.G2122E	C	C		7	Cancer Module	2	238267721	238267721	539	0.37847866419295	NA	NA	NA			217	Collagen-like 2.|Triple-helical region.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238267721,C,C&fts=all">p.G2122E</a>
CRH	Missense_Mutation	p.R150K	C	C		7	Cancer Module	8	67089264	67089264	59	0.338983050847458	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,67089264,C,C&fts=all">p.R150K</a>
CSMD3	Missense_Mutation	p.E171K	C	C	rs536561292	7	Cancer Module	8	114290824	114290824	143	0.391608391608392	NA	NA	NA			646	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,114290824,C,C&fts=all">p.E171K</a>
DDX3X	Frame_Shift_Del	p.T384fs	T	T		7	Cancer Module	X	41204559	41204559	244	0.790983606557377	NA	NA	NA			84	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.|Interaction with GSK3B.|Necessary for interaction with XPO1.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX3X&recr=Open">Click here</a>	
DHRS4	Missense_Mutation	p.R64Q	G	G	rs79086208	7	Cancer Module	14	24424306	24424306	287	0.0174216027874564	NA	NA	NA			14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24424306,G,G&fts=all">p.R64Q</a>
DLC1	Missense_Mutation	p.P307L	G	G		7	Cancer Module	8	13356661	13356661	276	0.36231884057971	NA	NA	NA			110			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,13356661,G,G&fts=all">p.P307L</a>
DNAH5	Missense_Mutation	p.S2989L	G	G		7	Cancer Module	5	13777450	13777450	179	0.418994413407821	NA	NA	NA			378	AAA 4. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13777450,G,G&fts=all">p.S2989L</a>
DNAH5	Missense_Mutation	p.R2425C	G	G	rs376707969	7	Cancer Module	5	13811890	13811890	216	0.444444444444444	NA	NA	NA			378	AAA 2. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13811890,G,G&fts=all">p.R2425C</a>
DNAJC10	Missense_Mutation	p.G256S	G	G		7	Cancer Module	2	183595795	183595795	288	0.315972222222222	NA	NA	NA			32	Trxb 1.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,183595795,G,G&fts=all">p.G256S</a>
DPYSL2	Missense_Mutation	p.R481H	G	G		7	Cancer Module	8	26509933	26509933	316	0.0189873417721519	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYSL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,26509933,G,G&fts=all">p.R481H</a>
DYNC1H1	Splice_Site		G	G		7	Cancer Module	14	102496155	102496155	346	0.326589595375723	NA	NA	NA			166			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYNC1H1&recr=Open">Click here</a>	
EIF3H	Missense_Mutation	p.L257P	A	A		7	Cancer Module	8	117661145	117661145	232	0.327586206896552	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF3H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,117661145,A,A&fts=all">p.L257P</a>
ELAVL4	Missense_Mutation	p.R162Q	G	G		7	Cancer Module	1	50659567	50659567	406	0.394088669950739	NA	NA	NA			32	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELAVL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,50659567,G,G&fts=all">p.R162Q</a>
F11R	Missense_Mutation	p.R59C	G	G		7	Cancer Module	1	160970876	160970876	189	0.571428571428571	NA	NA	NA			12	Ig-like V-type 1.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F11R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160970876,G,G&fts=all">p.R59C</a>
FAM135B	Missense_Mutation	p.G1110R	C	C		7	Cancer Module	8	139160883	139160883	115	0.382608695652174	NA	NA	NA			238			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139160883,C,C&fts=all">p.G1110R</a>
FCRL1	Missense_Mutation	p.G272E	C	C		7	Cancer Module	1	157771776	157771776	262	0.278625954198473	NA	NA	NA			42	Ig-like C2-type 3.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157771776,C,C&fts=all">p.G272E</a>
FECH	Missense_Mutation	p.E393K	C	C		7	Cancer Module	18	55218039	55218039	109	0.422018348623853	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FECH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,55218039,C,C&fts=all">p.E393K</a>
FLT1	Missense_Mutation	p.I604L	T	T		7	Cancer Module	13	28964092	28964092	289	0.332179930795848	NA	NA	NA			115	Ig-like C2-type 6.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28964092,T,T&fts=all">p.I604L</a>
GALNT13	Missense_Mutation	p.S186F	C	C		7	Cancer Module	2	155099289	155099289	201	0.368159203980099	NA	NA	NA			65	Catalytic subdomain A.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155099289,C,C&fts=all">p.S186F</a>
GC	Missense_Mutation	p.G78E	C	C		7	Cancer Module	4	72634046	72634046	73	0.356164383561644	NA	NA	NA			45	Albumin 1. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,72634046,C,C&fts=all">p.G78E</a>
GCM2	Missense_Mutation	p.R345K	C	C		7	Cancer Module	6	10874715	10874715	380	0.257894736842105	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,10874715,C,C&fts=all">p.R345K</a>
GLRA3	Missense_Mutation	p.R62K	C	C		7	Cancer Module	4	175709981	175709981	244	0.344262295081967	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175709981,C,C&fts=all">p.R62K</a>
GSTA3	Missense_Mutation	p.E126K	C	C		7	Cancer Module	6	52764770	52764770	890	0.225842696629213	NA	NA	NA			10	GST C-terminal.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52764770,C,C&fts=all">p.E126K</a>
HOOK1	Missense_Mutation	p.P169L	C	C		7	Cancer Module	1	60302576	60302576	180	0.316666666666667	NA	NA	NA			29	Sufficient for interaction with microtubules.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOOK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,60302576,C,C&fts=all">p.P169L</a>
HPS4	Missense_Mutation	p.P71L	G	G		7	Cancer Module	22	26873023	26873023	226	0.0221238938053097	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26873023,G,G&fts=all">p.P71L</a>
HRASLS	Missense_Mutation	p.R232C	C	C		7	Cancer Module	3	192980998	192980998	217	0.36405529953917	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRASLS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,192980998,C,C&fts=all">p.R232C</a>
ITGB6	Nonsense_Mutation	p.Q46*	G	G		7	Cancer Module	2	161055695	161055695	169	0.396449704142012	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,161055695,G,G&fts=all">p.Q46*</a>
KCNAB1	Missense_Mutation	p.R205Q	G	G	rs377418577	7	Cancer Module	3	156232162	156232162	211	0.360189573459716	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,156232162,G,G&fts=all">p.R205Q</a>
KCNB2	Missense_Mutation	p.P369S	C	C		7	Cancer Module	8	73848695	73848695	317	0.359621451104101	NA	NA	NA			85			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,73848695,C,C&fts=all">p.P369S</a>
KCND3	Missense_Mutation	p.G371R	C	C		7	Cancer Module	1	112329724	112329724	40	0.375	NA	NA	NA			49			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,112329724,C,C&fts=all">p.G371R</a>
KLHL32	Missense_Mutation	p.D570N	G	G		7	Cancer Module	6	97587003	97587003	148	0.709459459459459	NA	NA	NA			38			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,97587003,G,G&fts=all">p.D570N</a>
KRT31	Missense_Mutation	p.E148K	C	C		7	Cancer Module	17	39552818	39552818	131	0.374045801526718	NA	NA	NA			31	Coil 1B.|Rod.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39552818,C,C&fts=all">p.E148K</a>
LARGE	Missense_Mutation	p.S15L	G	G		7	Cancer Module	22	34157420	34157420	267	0.359550561797753	NA	NA	NA			51			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LARGE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,34157420,G,G&fts=all">p.S15L</a>
LECT1	Nonsense_Mutation	p.W325*	C	C		7	Cancer Module	13	53277761	53277761	158	0.310126582278481	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LECT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53277761,C,C&fts=all">p.W325*</a>
LIG4	Missense_Mutation	p.P579L	G	G		7	Cancer Module	13	108861881	108861881	126	0.396825396825397	NA	NA	NA			42			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,108861881,G,G&fts=all">p.P579L</a>
LLGL2	Missense_Mutation	p.S746F	C	C	rs143013538	7	Cancer Module	17	73567808	73567808	83	0.44578313253012	NA	NA	NA			31			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73567808,C,C&fts=all">p.S746F</a>
MAP1S	Missense_Mutation	p.R820C	C	C		7	Cancer Module	19	17838651	17838651	49	0.469387755102041	NA	NA	NA			25	Necessary for association with microtubules.|Necessary for interaction with RASSF1 isoform A and isoform C.|Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1S&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17838651,C,C&fts=all">p.R820C</a>
MOV10L1	Missense_Mutation	p.M738I	G	G		7	Cancer Module	22	50581506	50581506	229	0.419213973799127	NA	NA	NA			67			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50581506,G,G&fts=all">p.M738I</a>
MSH5	Missense_Mutation	p.P397S	C	C		7	Cancer Module	6	31726370	31726370	211	0.241706161137441	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31726370,C,C&fts=all">p.P397S</a>
MTMR12	Missense_Mutation	p.A187V	G	G		7	Cancer Module	5	32268830	32268830	349	0.0143266475644699	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32268830,G,G&fts=all">p.A187V</a>
MUC16	Missense_Mutation	p.S11510F	G	G		7	Cancer Module	19	9047102	9047102	138	0.152173913043478	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9047102,G,G&fts=all">p.S11510F</a>
MYH8	Missense_Mutation	p.M1621I	C	C		7	Cancer Module	17	10298549	10298549	273	0.457875457875458	NA	NA	NA			134			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10298549,C,C&fts=all">p.M1621I</a>
NAALAD2	Missense_Mutation	p.E54K	G	G		7	Cancer Module	11	89868804	89868804	240	0.0208333333333333	NA	NA	NA			59			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAALAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,89868804,G,G&fts=all">p.E54K</a>
NEB	Missense_Mutation	p.E1990K	C	C	rs146310692	7	Cancer Module	2	152518651	152518651	58	0.396551724137931	NA	NA	NA			301			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152518651,C,C&fts=all">p.E1990K</a>
NID2	Missense_Mutation	p.D674N	C	C		7	Cancer Module	14	52507375	52507375	245	0.383673469387755	NA	NA	NA			87	Nidogen G2 beta-barrel. {ECO:0000255|PROSITE-ProRule:PRU00348}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,52507375,C,C&fts=all">p.D674N</a>
NLRC5	Missense_Mutation	p.F259I	T	T		7	Cancer Module	16	57059630	57059630	234	0.401709401709402	NA	NA	NA			75	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57059630,T,T&fts=all">p.F259I</a>
NOL4	Missense_Mutation	p.R140Q	C	C		7	Cancer Module	18	31537444	31537444	81	0.419753086419753	NA	NA	NA			51			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31537444,C,C&fts=all">p.R140Q</a>
NOX4	Missense_Mutation	p.H352Y	G	G		7	Cancer Module	11	89133205	89133205	136	0.367647058823529	NA	NA	NA			44	FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.|Mediates interaction with TLR4.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,89133205,G,G&fts=all">p.H352Y</a>
OGDH	Missense_Mutation	p.E792K	G	G		7	Cancer Module	7	44737818	44737818	284	0.355633802816901	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44737818,G,G&fts=all">p.E792K</a>
OGDHL	Missense_Mutation	p.G772S	C	C		7	Cancer Module	10	50947712	50947712	59	0.322033898305085	NA	NA	NA			61			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDHL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50947712,C,C&fts=all">p.G772S</a>
OSBPL2	Missense_Mutation	p.G208D	G	G		7	Cancer Module	20	60854344	60854344	140	0.0285714285714286	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,60854344,G,G&fts=all">p.G208D</a>
PASK	Missense_Mutation	p.P980S	G	G		7	Cancer Module	2	242062281	242062281	79	0.30379746835443	NA	NA	NA			53			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PASK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242062281,G,G&fts=all">p.P980S</a>
PCCA	Splice_Site	p.T706T	G	G		7	Cancer Module	13	101180006	101180006	184	0.0271739130434783	NA	NA	NA		p.T706T(1)	26	Biotinyl-binding. {ECO:0000255|PROSITE- ProRule:PRU01066}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCCA&recr=Open">Click here</a>	
PLA2R1	Missense_Mutation	p.P600S	G	G		7	Cancer Module	2	160862199	160862199	223	0.385650224215247	NA	NA	NA			60	C-type lectin 3. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160862199,G,G&fts=all">p.P600S</a>
PROX1	Missense_Mutation	p.P143L	C	C		7	Cancer Module	1	214170306	214170306	372	0.497311827956989	NA	NA	NA			47			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,214170306,C,C&fts=all">p.P143L</a>
PTPN13	Missense_Mutation	p.S887L	C	C		7	Cancer Module	4	87671632	87671632	398	0.391959798994975	NA	NA	NA		p.S887L(2)	93			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,87671632,C,C&fts=all">p.S887L</a>
PYCR1	Missense_Mutation	p.G83D	C	C	rs560921348	7	Cancer Module	17	79893283	79893283	53	0.339622641509434	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PYCR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,79893283,C,C&fts=all">p.G83D</a>
RABGAP1	Missense_Mutation	p.P400L	C	C		7	Cancer Module	9	125759635	125759635	43	0.534883720930233	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125759635,C,C&fts=all">p.P400L</a>
RPE65	Missense_Mutation	p.T18I	G	G		7	Cancer Module	1	68914348	68914348	197	0.319796954314721	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPE65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,68914348,G,G&fts=all">p.T18I</a>
RTKN	Missense_Mutation	p.L242F	G	G		7	Cancer Module	2	74655841	74655841	52	0.461538461538462	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTKN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74655841,G,G&fts=all">p.L242F</a>
RYR2	Missense_Mutation	p.E4472K	G	G		7	Cancer Module	1	237951373	237951373	77	0.233766233766234	NA	NA	NA			586			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237951373,G,G&fts=all">p.E4472K</a>
RYR3	Missense_Mutation	p.E3445K	G	G		7	Cancer Module	15	34105139	34105139	145	0.303448275862069	NA	NA	NA			311			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34105139,G,G&fts=all">p.E3445K</a>
S100A12	Missense_Mutation	p.A79V	G	G		7	Cancer Module	1	153346346	153346346	228	0.258771929824561	NA	NA	NA			4	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S100A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153346346,G,G&fts=all">p.A79V</a>
SATB1	Missense_Mutation	p.S684L	G	G		7	Cancer Module	3	18390999	18390999	197	0.360406091370558	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SATB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,18390999,G,G&fts=all">p.S684L</a>
SCTR	Missense_Mutation	p.G55E	C	C		7	Cancer Module	2	120252033	120252033	97	0.422680412371134	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCTR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,120252033,C,C&fts=all">p.G55E</a>
SERPINB7	Missense_Mutation	p.E119K	G	G		7	Cancer Module	18	61463518	61463518	184	0.364130434782609	NA	NA	NA		p.E119*(1)	27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,61463518,G,G&fts=all">p.E119K</a>
SF3A1	Missense_Mutation	p.L204F	G	G		7	Cancer Module	22	30740963	30740963	308	0.415584415584416	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30740963,G,G&fts=all">p.L204F</a>
SIN3A	Frame_Shift_Del	p.M896fs	T	T		7	Cancer Module	15	75684748	75684748	228	0.464912280701754	NA	NA	NA			63			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIN3A&recr=Open">Click here</a>	
SLC22A18	Missense_Mutation	p.G76R	G	G		7	Cancer Module	11	2929544	2929544	121	0.0330578512396694	NA	NA	NA			8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,2929544,G,G&fts=all">p.G76R</a>
SLC22A8	Missense_Mutation	p.E287K	C	C		7	Cancer Module	11	62763527	62763527	153	0.38562091503268	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62763527,C,C&fts=all">p.E287K</a>
SLC26A3	Missense_Mutation	p.G593R	C	C		7	Cancer Module	7	107414595	107414595	201	0.308457711442786	NA	NA	NA			46	STAS. {ECO:0000255|PROSITE- ProRule:PRU00198}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107414595,C,C&fts=all">p.G593R</a>
SLC30A3	Missense_Mutation	p.D266N	C	C		7	Cancer Module	2	27479743	27479743	79	0.379746835443038	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27479743,C,C&fts=all">p.D266N</a>
SLC38A2	Nonsense_Mutation	p.Q178*	G	G		7	Cancer Module	12	46760678	46760678	324	0.330246913580247	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46760678,G,G&fts=all">p.Q178*</a>
SLC6A1	Missense_Mutation	p.P71S	C	C		7	Cancer Module	3	11059108	11059108	106	0.330188679245283	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,11059108,C,C&fts=all">p.P71S</a>
SLC6A1	Missense_Mutation	p.P71L	C	C		7	Cancer Module	3	11059109	11059109	106	0.330188679245283	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,11059109,C,C&fts=all">p.P71L</a>
SLC6A1	Missense_Mutation	p.G75E	G	G		7	Cancer Module	3	11059121	11059121	99	0.393939393939394	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,11059121,G,G&fts=all">p.G75E</a>
SLIT2	Missense_Mutation	p.S373F	C	C		7	Cancer Module	4	20521064	20521064	197	0.350253807106599	NA	NA	NA			116			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,20521064,C,C&fts=all">p.S373F</a>
SMG7	Missense_Mutation	p.H401Y	C	C		7	Cancer Module	1	183506317	183506317	411	0.515815085158151	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,183506317,C,C&fts=all">p.H401Y</a>
SMYD1	Missense_Mutation	p.E355K	G	G		7	Cancer Module	2	88405964	88405964	183	0.377049180327869	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMYD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,88405964,G,G&fts=all">p.E355K</a>
SP140	Missense_Mutation	p.D638N	G	G		7	Cancer Module	2	231174672	231174672	271	0.328413284132841	NA	NA	NA			12	SAND. {ECO:0000255|PROSITE- ProRule:PRU00185}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP140&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,231174672,G,G&fts=all">p.D638N</a>
SSH1	Missense_Mutation	p.P728S	G	G		7	Cancer Module	12	109182732	109182732	161	0.354037267080745	NA	NA	NA			38			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,109182732,G,G&fts=all">p.P728S</a>
STAB1	Splice_Site	p.E140K	G	G		7	Cancer Module	3	52536175	52536175	53	0.39622641509434	NA	NA	NA			76	EGF-like 1. {ECO:0000255|PROSITE- ProRule:PRU00076, ECO:0000305}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
SULF1	Missense_Mutation	p.P758S	C	C		7	Cancer Module	8	70541902	70541902	313	0.332268370607029	NA	NA	NA			52			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70541902,C,C&fts=all">p.P758S</a>
SVEP1	Missense_Mutation	p.D3173N	C	C	rs267602083	7	Cancer Module	9	113166687	113166687	417	0.597122302158273	NA	NA	NA			147	Sushi 29. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113166687,C,C&fts=all">p.D3173N</a>
SYT8	Missense_Mutation	p.S208L	C	C	rs200240009	7	Cancer Module	11	1857719	1857719	23	0.347826086956522	NA	NA	NA			6	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,1857719,C,C&fts=all">p.S208L</a>
TAF2	Missense_Mutation	p.S282L	G	G		7	Cancer Module	8	120810034	120810034	151	0.317880794701987	NA	NA	NA			49			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,120810034,G,G&fts=all">p.S282L</a>
TGM1	Missense_Mutation	p.S479F	G	G		7	Cancer Module	14	24725250	24725250	20	0.35	NA	NA	NA			24			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24725250,G,G&fts=all">p.S479F</a>
TGM2	Missense_Mutation	p.S415F	G	G		7	Cancer Module	20	36767912	36767912	192	0.385416666666667	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36767912,G,G&fts=all">p.S415F</a>
TLE1	Missense_Mutation	p.P564S	G	G		7	Cancer Module	9	84205859	84205859	132	0.712121212121212	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,84205859,G,G&fts=all">p.P564S</a>
TMEM190	Splice_Site		G	G		7	Cancer Module	19	55889255	55889255	73	0.465753424657534	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM190&recr=Open">Click here</a>	
TNFAIP2	Missense_Mutation	p.T416R	C	C		7	Cancer Module	14	103597436	103597436	239	0.430962343096234	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFAIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,103597436,C,C&fts=all">p.T416R</a>
TNR	Nonsense_Mutation	p.W1093*	C	C		7	Cancer Module	1	175323630	175323630	246	0.560975609756098	NA	NA	NA			177	Fibronectin type-III 9. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175323630,C,C&fts=all">p.W1093*</a>
TRAT1	Missense_Mutation	p.H32Y	C	C		7	Cancer Module	3	108549603	108549603	278	0.334532374100719	NA	NA	NA		p.H32N(1)	28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108549603,C,C&fts=all">p.H32Y</a>
TTN	Missense_Mutation	p.S153L	G	G		7	Cancer Module	2	179665247	179665247	286	0.339160839160839	NA	NA	NA			1448	Ig-like 2.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179665247,G,G&fts=all">p.S153L</a>
UGDH	Missense_Mutation	p.P480L	G	G		7	Cancer Module	4	39501809	39501809	248	0.0201612903225806	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,39501809,G,G&fts=all">p.P480L</a>
USH2A	Nonsense_Mutation	p.W3521*	C	C		7	Cancer Module	1	215956102	215956102	299	0.247491638795987	NA	NA	NA			527	Fibronectin type-III 20. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,215956102,C,C&fts=all">p.W3521*</a>
VARS	Missense_Mutation	p.A226V	G	G		7	Cancer Module	6	31760278	31760278	230	0.221739130434783	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VARS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31760278,G,G&fts=all">p.A226V</a>
VPS39	Missense_Mutation	p.I746S	A	A		7	Cancer Module	15	42454618	42454618	118	0.338983050847458	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42454618,A,A&fts=all">p.I746S</a>
VWF	Splice_Site	p.G2086E	C	C		7	Cancer Module	12	6103369	6103369	136	0.389705882352941	NA	NA	NA			129	VWFD 4. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
ZFPM2	Missense_Mutation	p.S1111F	C	C		7	Cancer Module	8	106815642	106815642	85	0.447058823529412	NA	NA	NA			99			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106815642,C,C&fts=all">p.S1111F</a>
ZFR	Missense_Mutation	p.R681C	G	G		7	Cancer Module	5	32390482	32390482	195	0.379487179487179	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32390482,G,G&fts=all">p.R681C</a>
ZNF239	Missense_Mutation	p.P39S	G	G		7	Cancer Module	10	44053413	44053413	306	0.395424836601307	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF239&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,44053413,G,G&fts=all">p.P39S</a>
ZRANB1	Missense_Mutation	p.W163R	T	T		7	Cancer Module	10	126631549	126631549	299	0.397993311036789	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZRANB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,126631549,T,T&fts=all">p.W163R</a>
HIPK4	Missense_Mutation	p.E15K	C	C	rs377107606	7.75	Cancer Gene	19	40895767	40895767	90	0.322222222222222	NA	NA	NA			20	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40895767,C,C&fts=all">p.E15K</a>
STK40	Missense_Mutation	p.P39L	G	G	rs570552548	7.75	Cancer Gene	1	36824420	36824420	141	0.453900709219858	NA	NA	NA			13	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36824420,G,G&fts=all">p.P39L</a>
ACRC	Missense_Mutation	p.S204L	C	C		8	Cancer Gene	X	70823738	70823738	453	0.76158940397351	NA	NA	NA			54	Asp/Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70823738,C,C&fts=all">p.S204L</a>
ADAM18	Missense_Mutation	p.G312E	G	G		8	Cancer Gene	8	39502882	39502882	262	0.404580152671756	NA	NA	NA			71	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39502882,G,G&fts=all">p.G312E</a>
ADAMTS20	Missense_Mutation	p.G770E	C	C		8	Cancer Gene	12	43833854	43833854	25	0.12	NA	NA	NA			95	Spacer.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43833854,C,C&fts=all">p.G770E</a>
AGBL4	Frame_Shift_Del	p.M186fs	AT	AT		8	Cancer Gene	1	49511293	49511294	74	0.297297297297297	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL4&recr=Open">Click here</a>	
ANKAR	Missense_Mutation	p.F1105L	T	T		8	Cancer Gene	2	190597847	190597847	231	0.411255411255411	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKAR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,190597847,T,T&fts=all">p.F1105L</a>
ARAP1	Missense_Mutation	p.R726W	G	G	rs371551738	8	Cancer Gene	11	72412820	72412820	452	0.420353982300885	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,72412820,G,G&fts=all">p.R726W</a>
ARAP2	Missense_Mutation	p.E1548K	C	C		8	Cancer Gene	4	36075412	36075412	380	0.371052631578947	NA	NA	NA			82			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36075412,C,C&fts=all">p.E1548K</a>
ARFGAP1	Missense_Mutation	p.L10F	C	C	rs148760592	8	Cancer Gene	20	61906960	61906960	131	0.305343511450382	NA	NA	NA			13	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARFGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,61906960,C,C&fts=all">p.L10F</a>
ARGFX	Missense_Mutation	p.P150S	C	C		8	Cancer Gene	3	121304947	121304947	169	0.378698224852071	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARGFX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121304947,C,C&fts=all">p.P150S</a>
ARHGEF15	Missense_Mutation	p.R245Q	G	G		8	Cancer Gene	17	8216372	8216372	156	0.33974358974359	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,8216372,G,G&fts=all">p.R245Q</a>
ARMC4	Missense_Mutation	p.K580N	T	T		8	Cancer Gene	10	28233154	28233154	55	0.345454545454545	NA	NA	NA			75			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28233154,T,T&fts=all">p.K580N</a>
ARMC4	Missense_Mutation	p.E520K	C	C		8	Cancer Gene	10	28233336	28233336	148	0.405405405405405	NA	NA	NA			75			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28233336,C,C&fts=all">p.E520K</a>
ARMC4	Missense_Mutation	p.E246K	C	C		8	Cancer Gene	10	28272855	28272855	178	0.393258426966292	NA	NA	NA			75			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28272855,C,C&fts=all">p.E246K</a>
ASXL3	Missense_Mutation	p.H766Q	T	T		8	Cancer Gene	18	31319666	31319666	97	0.0515463917525773	NA	NA	NA			43	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31319666,T,T&fts=all">p.H766Q</a>
ATP13A5	Missense_Mutation	p.S601F	G	G		8	Cancer Gene	3	193039583	193039583	116	0.336206896551724	NA	NA	NA			76			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,193039583,G,G&fts=all">p.S601F</a>
ATP8B4	Missense_Mutation	p.E634K	C	C		8	Cancer Gene	15	50212466	50212466	323	0.371517027863777	NA	NA	NA		p.E634K(1)	73			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50212466,C,C&fts=all">p.E634K</a>
AXDND1	Splice_Site	p.S666L	C	C		8	Cancer Gene	1	179437776	179437776	134	0.559701492537313	NA	NA	NA		p.S666L(1)	59			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXDND1&recr=Open">Click here</a>	
BARHL1	Missense_Mutation	p.S34L	C	C		8	Cancer Gene	9	135458285	135458285	78	0.653846153846154	NA	NA	NA			8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BARHL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135458285,C,C&fts=all">p.S34L</a>
C17orf47	Missense_Mutation	p.P468L	G	G		8	Cancer Gene	17	56620145	56620145	495	0.363636363636364	NA	NA	NA			24			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56620145,G,G&fts=all">p.P468L</a>
C2orf48	Missense_Mutation	p.M114I	G	G		8	Cancer Gene	2	10350585	10350585	104	0.365384615384615	NA	NA	NA			8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf48&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,10350585,G,G&fts=all">p.M114I</a>
C6orf222	Missense_Mutation	p.G82R	C	C	rs373211877	8	Cancer Gene	6	36298224	36298224	280	0.0178571428571429	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf222&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,36298224,C,C&fts=all">p.G82R</a>
C7orf60	Missense_Mutation	p.P251L	G	G		8	Cancer Gene	7	112462265	112462265	102	0.42156862745098	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7orf60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,112462265,G,G&fts=all">p.P251L</a>
CACNA1E	Missense_Mutation	p.S1937L	C	C		8	Cancer Gene	1	181759604	181759604	215	0.609302325581395	NA	NA	NA			204			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,181759604,C,C&fts=all">p.S1937L</a>
CACNA1S	Nonsense_Mutation	p.W417*	C	C		8	Cancer Gene	1	201052432	201052432	342	0.491228070175439	NA	NA	NA			102			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201052432,C,C&fts=all">p.W417*</a>
CAMTA1	Missense_Mutation	p.H154Y	C	C		8	Cancer Gene	1	7527911	7527911	204	0.607843137254902	NA	NA	NA			85			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,7527911,C,C&fts=all">p.H154Y</a>
CELF2	Missense_Mutation	p.L314I	C	C		8	Cancer Gene	10	11356158	11356158	215	0.348837209302326	NA	NA	NA			16	Ala-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,11356158,C,C&fts=all">p.L314I</a>
CHDH	Missense_Mutation	p.E65K	C	C		8	Cancer Gene	3	53857843	53857843	20	0.35	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,53857843,C,C&fts=all">p.E65K</a>
CIRH1A	Missense_Mutation	p.P132Q	C	C		8	Cancer Gene	16	69171747	69171747	202	0.257425742574257	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIRH1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,69171747,C,C&fts=all">p.P132Q</a>
CMYA5	Missense_Mutation	p.G3363E	G	G		8	Cancer Gene	5	79034676	79034676	124	0.42741935483871	NA	NA	NA			128			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79034676,G,G&fts=all">p.G3363E</a>
CSMD1	Missense_Mutation	p.P1122L	G	G		8	Cancer Gene	8	3205626	3205626	65	0.292307692307692	NA	NA	NA			25	CUB 7. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3205626,G,G&fts=all">p.P1122L</a>
DCAF4L2	Missense_Mutation	p.R5K	C	C		8	Cancer Gene	8	88886186	88886186	110	0.309090909090909	NA	NA	NA			83			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF4L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,88886186,C,C&fts=all">p.R5K</a>
DCLK2	Missense_Mutation	p.R656W	C	C		8	Cancer Gene	4	151169496	151169496	336	0.348214285714286	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,151169496,C,C&fts=all">p.R656W</a>
DDX50	Splice_Site		G	G		8	Cancer Gene	10	70695761	70695761	130	0.315384615384615	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX50&recr=Open">Click here</a>	
DDX60L	Missense_Mutation	p.P1327S	G	G		8	Cancer Gene	4	169305900	169305900	83	0.313253012048193	NA	NA	NA			43	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,169305900,G,G&fts=all">p.P1327S</a>
DNAH10	Missense_Mutation	p.E1079K	G	G		8	Cancer Gene	12	124298155	124298155	254	0.220472440944882	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124298155,G,G&fts=all">p.E1079K</a>
DNAH10	Missense_Mutation	p.E1079A	A	A		8	Cancer Gene	12	124298156	124298156	259	0.216216216216216	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124298156,A,A&fts=all">p.E1079A</a>
DNAH10	Nonsense_Mutation	p.W1406*	G	G		8	Cancer Gene	12	124317687	124317687	56	0.285714285714286	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124317687,G,G&fts=all">p.W1406*</a>
DNAH17	Missense_Mutation	p.M2436I	C	C		8	Cancer Gene	17	76481792	76481792	171	0.339181286549708	NA	NA	NA			116	AAA 3. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76481792,C,C&fts=all">p.M2436I</a>
DNAH2	Missense_Mutation	p.R4150W	C	C		8	Cancer Gene	17	7734621	7734621	213	0.375586854460094	NA	NA	NA			189			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7734621,C,C&fts=all">p.R4150W</a>
DPP10	Missense_Mutation	p.P31H	C	C		8	Cancer Gene	2	116066834	116066834	126	0.46031746031746	NA	NA	NA			101	Mediates effects on KCND2.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,116066834,C,C&fts=all">p.P31H</a>
DROSHA	Missense_Mutation	p.R364C	G	G		8	Cancer Gene	5	31515295	31515295	305	0.360655737704918	NA	NA	NA		p.R364S(1)	66			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DROSHA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,31515295,G,G&fts=all">p.R364C</a>
DSC1	Missense_Mutation	p.G809E	C	C		8	Cancer Gene	18	28711618	28711618	250	0.384	NA	NA	NA			53			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28711618,C,C&fts=all">p.G809E</a>
DTNA	Missense_Mutation	p.P561L	C	C		8	Cancer Gene	18	32455222	32455222	126	0.333333333333333	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DTNA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,32455222,C,C&fts=all">p.P561L</a>
ELFN2	Missense_Mutation	p.R420C	G	G	rs375922851	8	Cancer Gene	22	37770317	37770317	186	0.0268817204301075	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37770317,G,G&fts=all">p.R420C</a>
ENDOU	Missense_Mutation	p.K118E	T	T		8	Cancer Gene	12	48111331	48111331	279	0.390681003584229	NA	NA	NA			14	SMB 2. {ECO:0000255|PROSITE- ProRule:PRU00350}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENDOU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48111331,T,T&fts=all">p.K118E</a>
ERI3	Nonsense_Mutation	p.K251*	T	T		8	Cancer Gene	1	44773989	44773989	653	0.361408882082695	NA	NA	NA			16	Exonuclease.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERI3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44773989,T,T&fts=all">p.K251*</a>
FAM155B	Missense_Mutation	p.E331K	G	G		8	Cancer Gene	X	68748965	68748965	27	0.666666666666667	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM155B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,68748965,G,G&fts=all">p.E331K</a>
FAM24B	Missense_Mutation	p.P85L	G	G		8	Cancer Gene	10	124608794	124608794	194	0.365979381443299	NA	NA	NA			4			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM24B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124608794,G,G&fts=all">p.P85L</a>
FAM65A	Splice_Site	p.A1144T	G	G		8	Cancer Gene	16	67579852	67579852	227	0.440528634361233	NA	NA	NA			39			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65A&recr=Open">Click here</a>	
FAT3	Missense_Mutation	p.V801A	T	T		8	Cancer Gene	11	92088130	92088130	298	0.348993288590604	NA	NA	NA			85	Cadherin 7. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92088130,T,T&fts=all">p.V801A</a>
FBXL20	Missense_Mutation	p.P418L	G	G		8	Cancer Gene	17	37417771	37417771	229	0.349344978165939	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37417771,G,G&fts=all">p.P418L</a>
FKBP10	Missense_Mutation	p.P247S	C	C		8	Cancer Gene	17	39975473	39975473	224	0.352678571428571	NA	NA	NA			14	PPIase FKBP-type 2. {ECO:0000255|PROSITE- ProRule:PRU00277}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FKBP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39975473,C,C&fts=all">p.P247S</a>
FLG	Missense_Mutation	p.E3259K	C	C		8	Cancer Gene	1	152277587	152277587	892	0.283632286995516	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152277587,C,C&fts=all">p.E3259K</a>
FLG2	Missense_Mutation	p.G1063S	C	C		8	Cancer Gene	1	152327075	152327075	930	0.247311827956989	NA	NA	NA			188	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152327075,C,C&fts=all">p.G1063S</a>
FSCB	Missense_Mutation	p.E473K	C	C		8	Cancer Gene	14	44974774	44974774	181	0.458563535911602	NA	NA	NA			89	Ala-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSCB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,44974774,C,C&fts=all">p.E473K</a>
GDF3	Missense_Mutation	p.E203K	C	C		8	Cancer Gene	12	7842962	7842962	169	0.355029585798817	NA	NA	NA		p.E203K(1)	28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7842962,C,C&fts=all">p.E203K</a>
GEMIN5	Missense_Mutation	p.S700L	G	G		8	Cancer Gene	5	154291355	154291355	151	0.410596026490066	NA	NA	NA			38			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GEMIN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,154291355,G,G&fts=all">p.S700L</a>
GPR63	Missense_Mutation	p.F180L	A	A		8	Cancer Gene	6	97247070	97247070	258	0.383720930232558	NA	NA	NA			25			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR63&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,97247070,A,A&fts=all">p.F180L</a>
GRIN3A	Missense_Mutation	p.D582N	C	C		8	Cancer Gene	9	104432950	104432950	120	0.6	NA	NA	NA			80			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,104432950,C,C&fts=all">p.D582N</a>
HECW2	Missense_Mutation	p.S169F	G	G		8	Cancer Gene	2	197184040	197184040	153	0.372549019607843	NA	NA	NA			113			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197184040,G,G&fts=all">p.S169F</a>
HSPA12B	Missense_Mutation	p.C627G	T	T		8	Cancer Gene	20	3732631	3732631	17	0.529411764705882	NA	NA	NA			14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3732631,T,T&fts=all">p.C627G</a>
IFLTD1	Missense_Mutation	p.E170K	C	C		8	Cancer Gene	12	25679873	25679873	74	0.378378378378378	NA	NA	NA			22	LTD.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFLTD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,25679873,C,C&fts=all">p.E170K</a>
IGSF21	Missense_Mutation	p.E244K	G	G		8	Cancer Gene	1	18691906	18691906	74	0.621621621621622	NA	NA	NA			40			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,18691906,G,G&fts=all">p.E244K</a>
ILDR1	Missense_Mutation	p.G85S	C	C		8	Cancer Gene	3	121724217	121724217	100	0.34	NA	NA	NA			25	Ig-like V-type.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121724217,C,C&fts=all">p.G85S</a>
INADL	Nonsense_Mutation	p.Q195*	C	C		8	Cancer Gene	1	62237161	62237161	231	0.354978354978355	NA	NA	NA			103	PDZ 1. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62237161,C,C&fts=all">p.Q195*</a>
INO80E	Missense_Mutation	p.P99L	C	C		8	Cancer Gene	16	30012261	30012261	97	0.309278350515464	NA	NA	NA			6	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INO80E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30012261,C,C&fts=all">p.P99L</a>
IPCEF1	Missense_Mutation	p.H256Y	G	G		8	Cancer Gene	6	154520946	154520946	301	0.644518272425249	NA	NA	NA			12	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPCEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,154520946,G,G&fts=all">p.H256Y</a>
IRAK3	Missense_Mutation	p.P506S	C	C		8	Cancer Gene	12	66641676	66641676	225	0.417777777777778	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRAK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,66641676,C,C&fts=all">p.P506S</a>
ITGA11	Missense_Mutation	p.D798N	C	C		8	Cancer Gene	15	68613772	68613772	43	0.651162790697674	NA	NA	NA			52			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,68613772,C,C&fts=all">p.D798N</a>
KCNH7	Missense_Mutation	p.R876Q	C	C	rs375588527	8	Cancer Gene	2	163250982	163250982	179	0.273743016759777	NA	NA	NA			108			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163250982,C,C&fts=all">p.R876Q</a>
KCNH7	Missense_Mutation	p.S256F	G	G		8	Cancer Gene	2	163374365	163374365	235	0.370212765957447	NA	NA	NA			108			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163374365,G,G&fts=all">p.S256F</a>
KCNT2	Missense_Mutation	p.G1064S	C	C		8	Cancer Gene	1	196227345	196227345	368	0.445652173913043	NA	NA	NA			97			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196227345,C,C&fts=all">p.G1064S</a>
KCNU1	Missense_Mutation	p.P180S	C	C		8	Cancer Gene	8	36663856	36663856	67	0.313432835820896	NA	NA	NA			57			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,36663856,C,C&fts=all">p.P180S</a>
KDM6B	Missense_Mutation	p.P324L	C	C		8	Cancer Gene	17	7750484	7750484	150	0.42	NA	NA	NA			37	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7750484,C,C&fts=all">p.P324L</a>
LCT	Missense_Mutation	p.N1610S	T	T		8	Cancer Gene	2	136558214	136558214	198	0.388888888888889	NA	NA	NA			124	4 X approximate repeats.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,136558214,T,T&fts=all">p.N1610S</a>
LMX1A	Missense_Mutation	p.E139K	C	C		8	Cancer Gene	1	165218726	165218726	221	0.633484162895928	NA	NA	NA			35	LIM zinc-binding 2. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMX1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,165218726,C,C&fts=all">p.E139K</a>
MEGF8	Missense_Mutation	p.G2163D	G	G		8	Cancer Gene	19	42873730	42873730	293	0.621160409556314	NA	NA	NA			50	PSI 7.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42873730,G,G&fts=all">p.G2163D</a>
MGAT4C	Missense_Mutation	p.E415K	C	C		8	Cancer Gene	12	86373261	86373261	270	0.374074074074074	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,86373261,C,C&fts=all">p.E415K</a>
MST4	Missense_Mutation	p.E127K	G	G		8	Cancer Gene	X	131202291	131202291	223	0.834080717488789	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,131202291,G,G&fts=all">p.E127K</a>
MYH4	Missense_Mutation	p.D1588N	C	C		8	Cancer Gene	17	10351338	10351338	300	0.333333333333333	NA	NA	NA			149			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10351338,C,C&fts=all">p.D1588N</a>
MYO18B	Missense_Mutation	p.R2109Q	G	G		8	Cancer Gene	22	26399266	26399266	43	0.441860465116279	NA	NA	NA			146			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26399266,G,G&fts=all">p.R2109Q</a>
NCOA6	Missense_Mutation	p.T759M	G	G	rs187622379	8	Cancer Gene	20	33337722	33337722	106	0.0377358490566038	NA	NA	NA			107	CREBBP-binding region.|Gln-rich.|NCOA1-binding region.|TBP/GTF2A-binding region.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,33337722,G,G&fts=all">p.T759M</a>
NEK10	Missense_Mutation	p.P1162L	G	G		8	Cancer Gene	3	27152797	27152797	174	0.362068965517241	NA	NA	NA		p.P1115L(1)	41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,27152797,G,G&fts=all">p.P1162L</a>
NEUROD4	Missense_Mutation	p.E61K	G	G		8	Cancer Gene	12	55420404	55420404	57	0.263157894736842	NA	NA	NA			41	Asp/Glu-rich (acidic).		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEUROD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55420404,G,G&fts=all">p.E61K</a>
NLRP14	Missense_Mutation	p.D86N	G	G		8	Cancer Gene	11	7060073	7060073	91	0.406593406593407	NA	NA	NA			21	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7060073,G,G&fts=all">p.D86N</a>
OBSCN	Missense_Mutation	p.G2172E	G	G		8	Cancer Gene	1	228461723	228461723	115	0.226086956521739	NA	NA	NA			223	Ig-like 22.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228461723,G,G&fts=all">p.G2172E</a>
OBSCN	Missense_Mutation	p.R6924C	C	C		8	Cancer Gene	1	228529180	228529180	100	0.2	NA	NA	NA			223			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228529180,C,C&fts=all">p.R6924C</a>
OR10X1	Missense_Mutation	p.L298F	G	G		8	Cancer Gene	1	158548798	158548798	258	0.286821705426357	NA	NA	NA		p.L298I(2)	37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158548798,G,G&fts=all">p.L298F</a>
OR10Z1	Missense_Mutation	p.R50K	G	G		8	Cancer Gene	1	158576377	158576377	557	0.269299820466786	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158576377,G,G&fts=all">p.R50K</a>
OR2A25	Missense_Mutation	p.R21K	G	G	rs200982918	8	Cancer Gene	7	143771374	143771374	240	0.279166666666667	NA	NA	NA			24			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143771374,G,G&fts=all">p.R21K</a>
OR2H1	Missense_Mutation	p.L34F	C	C		8	Cancer Gene	6	29429646	29429646	483	0.240165631469979	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2H1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29429646,C,C&fts=all">p.L34F</a>
OR4C3	Missense_Mutation	p.L189F	C	C		8	Cancer Gene	11	48347057	48347057	404	0.267326732673267	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48347057,C,C&fts=all">p.L189F</a>
OR4M2	Missense_Mutation	p.P58S	C	C		8	Cancer Gene	15	22368747	22368747	1237	0.182700080840744	NA	NA	NA			63			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4M2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,22368747,C,C&fts=all">p.P58S</a>
OR4N5	Missense_Mutation	p.R224C	C	C	rs538673697	8	Cancer Gene	14	20612564	20612564	176	0.4375	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4N5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20612564,C,C&fts=all">p.R224C</a>
OR4X2	Missense_Mutation	p.G138R	G	G		8	Cancer Gene	11	48267067	48267067	199	0.391959798994975	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4X2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48267067,G,G&fts=all">p.G138R</a>
OR51B2	Missense_Mutation	p.S241F	G	G		8	Cancer Gene	11	5344806	5344806	100	0.45	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5344806,G,G&fts=all">p.S241F</a>
OR51D1	Missense_Mutation	p.A132V	C	C		8	Cancer Gene	11	4661415	4661415	119	0.378151260504202	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4661415,C,C&fts=all">p.A132V</a>
OR52E6	Missense_Mutation	p.H274Y	G	G		8	Cancer Gene	11	5862308	5862308	159	0.459119496855346	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52E6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5862308,G,G&fts=all">p.H274Y</a>
OR56B4	Missense_Mutation	p.F279L	T	T		8	Cancer Gene	11	6129843	6129843	240	0.354166666666667	NA	NA	NA			21			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,6129843,T,T&fts=all">p.F279L</a>
OR5M9	Missense_Mutation	p.M271I	C	C		8	Cancer Gene	11	56230065	56230065	216	0.351851851851852	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5M9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56230065,C,C&fts=all">p.M271I</a>
OR5P2	Missense_Mutation	p.H52Y	G	G		8	Cancer Gene	11	7818336	7818336	107	0.364485981308411	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5P2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7818336,G,G&fts=all">p.H52Y</a>
OR6A2	Missense_Mutation	p.P318S	G	G		8	Cancer Gene	11	6815988	6815988	201	0.353233830845771	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,6815988,G,G&fts=all">p.P318S</a>
OR6K2	Missense_Mutation	p.T136I	G	G		8	Cancer Gene	1	158670036	158670036	148	0.47972972972973	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6K2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158670036,G,G&fts=all">p.T136I</a>
OR9Q1	Missense_Mutation	p.G147E	G	G		8	Cancer Gene	11	57947356	57947356	139	0.431654676258993	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9Q1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,57947356,G,G&fts=all">p.G147E</a>
PACSIN1	Missense_Mutation	p.D283N	G	G	rs13200925	8	Cancer Gene	6	34498078	34498078	110	0.281818181818182	NA	NA	NA			13	F-BAR domain.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACSIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,34498078,G,G&fts=all">p.D283N</a>
PATL1	Missense_Mutation	p.S278F	G	G		8	Cancer Gene	11	59423194	59423194	32	0.53125	NA	NA	NA			11	Involved in RNA-binding.|Involved in nuclear foci localization.|Pro-rich.|Region N; interaction with decapping machinery.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PATL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59423194,G,G&fts=all">p.S278F</a>
PCDH15	Missense_Mutation	p.E1520K	C	C		8	Cancer Gene	10	55569252	55569252	351	0.276353276353276	NA	NA	NA			237			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55569252,C,C&fts=all">p.E1520K</a>
PCNXL2	Missense_Mutation	p.R786W	G	G		8	Cancer Gene	1	233372593	233372593	604	0.00993377483443709	NA	NA	NA			86			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,233372593,G,G&fts=all">p.R786W</a>
PDE1C	Missense_Mutation	p.R526K	C	C		8	Cancer Gene	7	31864490	31864490	286	0.311188811188811	NA	NA	NA			81			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,31864490,C,C&fts=all">p.R526K</a>
PKHD1L1	Missense_Mutation	p.D2209E	T	T		8	Cancer Gene	8	110465066	110465066	60	0.483333333333333	NA	NA	NA			263	G8 1. {ECO:0000255|PROSITE- ProRule:PRU00817}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110465066,T,T&fts=all">p.D2209E</a>
PPP1R13L	Missense_Mutation	p.P233L	G	G		8	Cancer Gene	19	45899817	45899817	13	0.461538461538462	NA	NA	NA			26	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R13L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,45899817,G,G&fts=all">p.P233L</a>
PRC1	Missense_Mutation	p.R392Q	C	C		8	Cancer Gene	15	91519934	91519934	423	0.335697399527187	NA	NA	NA			25			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91519934,C,C&fts=all">p.R392Q</a>
PREX2	Missense_Mutation	p.D465N	G	G		8	Cancer Gene	8	68981321	68981321	181	0.298342541436464	NA	NA	NA			178			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,68981321,G,G&fts=all">p.D465N</a>
PRUNE2	Missense_Mutation	p.P2278L	G	G		8	Cancer Gene	9	79320357	79320357	68	0.779411764705882	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79320357,G,G&fts=all">p.P2278L</a>
RASAL2	Missense_Mutation	p.R815I	G	G		8	Cancer Gene	1	178426871	178426871	271	0.250922509225092	NA	NA	NA			54			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,178426871,G,G&fts=all">p.R815I</a>
RASAL2	Missense_Mutation	p.G816R	G	G		8	Cancer Gene	1	178426873	178426873	272	0.261029411764706	NA	NA	NA			54			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,178426873,G,G&fts=all">p.G816R</a>
RASGRF1	Splice_Site		C	C		8	Cancer Gene	15	79323852	79323852	52	0.25	NA	NA	NA			71			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF1&recr=Open">Click here</a>	
RASSF9	Missense_Mutation	p.P124S	G	G	rs573615562	8	Cancer Gene	12	86199418	86199418	347	0.38328530259366	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASSF9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,86199418,G,G&fts=all">p.P124S</a>
RGS7BP	Missense_Mutation	p.H152Y	C	C		8	Cancer Gene	5	63871722	63871722	294	0.357142857142857	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS7BP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,63871722,C,C&fts=all">p.H152Y</a>
RPRD2	Missense_Mutation	p.S860L	C	C		8	Cancer Gene	1	150444003	150444003	133	0.609022556390977	NA	NA	NA			37	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150444003,C,C&fts=all">p.S860L</a>
SALL1	Missense_Mutation	p.D1099N	C	C		8	Cancer Gene	16	51172838	51172838	176	0.323863636363636	NA	NA	NA			126			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,51172838,C,C&fts=all">p.D1099N</a>
SCAF1	Missense_Mutation	p.S734F	C	C		8	Cancer Gene	19	50155847	50155847	15	0.533333333333333	NA	NA	NA			20	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50155847,C,C&fts=all">p.S734F</a>
SCN11A	Missense_Mutation	p.E1732K	C	C		8	Cancer Gene	3	38888367	38888367	590	0.386440677966102	NA	NA	NA			119			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38888367,C,C&fts=all">p.E1732K</a>
SETD1A	Missense_Mutation	p.S862F	C	C		8	Cancer Gene	16	30978284	30978284	15	0.333333333333333	NA	NA	NA			59			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETD1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30978284,C,C&fts=all">p.S862F</a>
SF3B4	Missense_Mutation	p.S277L	G	G		8	Cancer Gene	1	149897811	149897811	86	0.244186046511628	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,149897811,G,G&fts=all">p.S277L</a>
SLC13A5	Missense_Mutation	p.S313F	G	G		8	Cancer Gene	17	6599162	6599162	288	0.375	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,6599162,G,G&fts=all">p.S313F</a>
SLC25A41	Missense_Mutation	p.E362K	C	C		8	Cancer Gene	19	6426429	6426429	98	0.0408163265306122	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A41&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,6426429,C,C&fts=all">p.E362K</a>
SLC26A7	Missense_Mutation	p.P120S	C	C		8	Cancer Gene	8	92307812	92307812	268	0.376865671641791	NA	NA	NA			50			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92307812,C,C&fts=all">p.P120S</a>
SLC27A3	Missense_Mutation	p.G680R	G	G	rs200472466	8	Cancer Gene	1	153751597	153751597	740	0.258108108108108	NA	NA	NA			14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153751597,G,G&fts=all">p.G680R</a>
SLC39A11	Missense_Mutation	p.G74S	C	C	rs144527380	8	Cancer Gene	17	71027781	71027781	102	0.450980392156863	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71027781,C,C&fts=all">p.G74S</a>
SLC6A18	Missense_Mutation	p.L57F	C	C		8	Cancer Gene	5	1232342	1232342	27	0.37037037037037	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,1232342,C,C&fts=all">p.L57F</a>
SLCO6A1	Missense_Mutation	p.G37E	C	C		8	Cancer Gene	5	101834439	101834439	544	0.358455882352941	NA	NA	NA			60			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,101834439,C,C&fts=all">p.G37E</a>
SLTM	Missense_Mutation	p.S506L	G	G		8	Cancer Gene	15	59186151	59186151	162	0.351851851851852	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLTM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,59186151,G,G&fts=all">p.S506L</a>
SMG6	Missense_Mutation	p.E1166K	C	C		8	Cancer Gene	17	1989057	1989057	468	0.373931623931624	NA	NA	NA			45			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,1989057,C,C&fts=all">p.E1166K</a>
SNCAIP	Missense_Mutation	p.E299K	G	G		8	Cancer Gene	5	121759186	121759186	83	0.385542168674699	NA	NA	NA			39			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCAIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121759186,G,G&fts=all">p.E299K</a>
SOX7	Missense_Mutation	p.A79V	G	G		8	Cancer Gene	8	10689240	10689240	55	0.418181818181818	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10689240,G,G&fts=all">p.A79V</a>
SPHKAP	Missense_Mutation	p.E832K	C	C		8	Cancer Gene	2	228883076	228883076	862	0.372389791183295	NA	NA	NA			185			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228883076,C,C&fts=all">p.E832K</a>
SSBP3	Missense_Mutation	p.R45Q	C	C		8	Cancer Gene	1	54870306	54870306	301	0.372093023255814	NA	NA	NA			11	LisH. {ECO:0000255|PROSITE- ProRule:PRU00126}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,54870306,C,C&fts=all">p.R45Q</a>
STAG1	Missense_Mutation	p.R39H	C	C		8	Cancer Gene	3	136342004	136342004	414	0.0144927536231884	NA	NA	NA			58			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,136342004,C,C&fts=all">p.R39H</a>
STARD8	Nonsense_Mutation	p.Q746*	C	C		8	Cancer Gene	X	67940952	67940952	76	0.736842105263158	NA	NA	NA			50	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,67940952,C,C&fts=all">p.Q746*</a>
STXBP5L	Missense_Mutation	p.P80S	C	C		8	Cancer Gene	3	120673835	120673835	196	0.372448979591837	NA	NA	NA			68			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,120673835,C,C&fts=all">p.P80S</a>
STXBP5L	Splice_Site	p.G293E	G	G		8	Cancer Gene	3	120924770	120924770	105	0.285714285714286	NA	NA	NA			68			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5L&recr=Open">Click here</a>	
STXBP5L	Missense_Mutation	p.R1029Q	G	G	rs372264577	8	Cancer Gene	3	121132070	121132070	293	0.0170648464163823	NA	NA	NA			68			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121132070,G,G&fts=all">p.R1029Q</a>
SWT1	Missense_Mutation	p.P36L	C	C		8	Cancer Gene	1	185135726	185135726	427	0.245901639344262	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SWT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,185135726,C,C&fts=all">p.P36L</a>
SZT2	Missense_Mutation	p.S2439L	C	C		8	Cancer Gene	1	43907027	43907027	109	0.302752293577982	NA	NA	NA			113			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SZT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,43907027,C,C&fts=all">p.S2439L</a>
TAF1L	Missense_Mutation	p.S341F	G	G		8	Cancer Gene	9	32634556	32634556	124	0.653225806451613	NA	NA	NA			159			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32634556,G,G&fts=all">p.S341F</a>
TMEM201	Missense_Mutation	p.P380S	C	C		8	Cancer Gene	1	9662308	9662308	35	0.714285714285714	NA	NA	NA			4			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM201&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,9662308,C,C&fts=all">p.P380S</a>
TSHZ2	Missense_Mutation	p.R218Q	G	G		8	Cancer Gene	20	51870650	51870650	101	0.554455445544555	NA	NA	NA			84			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,51870650,G,G&fts=all">p.R218Q</a>
UBQLN3	Missense_Mutation	p.P334S	G	G	rs267602959	8	Cancer Gene	11	5529789	5529789	101	0.366336633663366	NA	NA	NA			39			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBQLN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5529789,G,G&fts=all">p.P334S</a>
URB2	Missense_Mutation	p.P190L	C	C		8	Cancer Gene	1	229770929	229770929	272	0.242647058823529	NA	NA	NA			73			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+URB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,229770929,C,C&fts=all">p.P190L</a>
UTP20	Missense_Mutation	p.K1319E	A	A		8	Cancer Gene	12	101732677	101732677	184	0.391304347826087	NA	NA	NA			88	Poly-Lys.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTP20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,101732677,A,A&fts=all">p.K1319E</a>
VPS16	Nonsense_Mutation	p.R605*	C	C		8	Cancer Gene	20	2845103	2845103	224	0.352678571428571	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2845103,C,C&fts=all">p.R605*</a>
WIPF3	Missense_Mutation	p.P312S	C	C		8	Cancer Gene	7	29924044	29924044	17	0.411764705882353	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WIPF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,29924044,C,C&fts=all">p.P312S</a>
ZCCHC4	Missense_Mutation	p.V145A	T	T		8	Cancer Gene	4	25334909	25334909	258	0.395348837209302	NA	NA	NA			9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25334909,T,T&fts=all">p.V145A</a>
ZDHHC11	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	5	837597	843841	NA	NA	3	-1.01216982346273	FALSE		NA	NA	NA		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC11&recr=Open">Click here</a>	
ZNF470	Missense_Mutation	p.H643Y	C	C		8	Cancer Gene	19	57089724	57089724	147	0.251700680272109	NA	NA	NA		p.H643Y(1)	41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF470&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57089724,C,C&fts=all">p.H643Y</a>
ZNF618	Missense_Mutation	p.L566F	C	C		8	Cancer Gene	9	116811278	116811278	31	0.580645161290323	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF618&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116811278,C,C&fts=all">p.L566F</a>
ZNF644	Missense_Mutation	p.R460C	G	G		8	Cancer Gene	1	91405533	91405533	256	0.3984375	NA	NA	NA			47			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF644&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91405533,G,G&fts=all">p.R460C</a>
ZNF687	Missense_Mutation	p.V621I	G	G		8	Cancer Gene	1	151260628	151260628	138	0.253623188405797	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF687&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151260628,G,G&fts=all">p.V621I</a>
ZNF804B	Missense_Mutation	p.P978S	C	C		8	Cancer Gene	7	88965228	88965228	302	0.417218543046358	NA	NA	NA			144			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88965228,C,C&fts=all">p.P978S</a>
ZNF804B	Missense_Mutation	p.P978L	C	C		8	Cancer Gene	7	88965229	88965229	293	0.41296928327645	NA	NA	NA			144			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88965229,C,C&fts=all">p.P978L</a>
ZNF835	Missense_Mutation	p.P277A	G	G		8	Cancer Gene	19	57175738	57175738	29	0.551724137931034	NA	NA	NA			47			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF835&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57175738,G,G&fts=all">p.P277A</a>
AGO4	Missense_Mutation	p.R100Q	G	G	rs528813399	10	SNP	1	36288576	36288576	242	0.380165289256198	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36288576,G,G&fts=all">p.R100Q</a>
AGO4	Missense_Mutation	p.P745L	C	C		10	SNP	1	36315816	36315816	341	0.360703812316716	NA	NA	NA				Piwi. {ECO:0000255|HAMAP-Rule:MF_03033}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36315816,C,C&fts=all">p.P745L</a>
BPIFB1	Missense_Mutation	p.E64K	G	G		10	SNP	20	31876621	31876621	75	0.373333333333333	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,31876621,G,G&fts=all">p.E64K</a>
BRINP2	Missense_Mutation	p.R615K	G	G		10	SNP	1	177250156	177250156	139	0.23021582733813	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,177250156,G,G&fts=all">p.R615K</a>
CATSPERD	Missense_Mutation	p.P696S	C	C		10	SNP	19	5776316	5776316	54	0.574074074074074	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,5776316,C,C&fts=all">p.P696S</a>
CTD-3074O7.11	Missense_Mutation	p.K537R	A	A		10	SNP	11	66298390	66298390	178	0.393258426966292	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3074O7.11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,66298390,A,A&fts=all">p.K537R</a>
CXXC11	Missense_Mutation	p.G274D	G	G	rs541685876	10	SNP	2	242814528	242814528	130	0.353846153846154	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXXC11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242814528,G,G&fts=all">p.G274D</a>
EMC7	Missense_Mutation	p.R44C	G	G		10	SNP	15	34393911	34393911	368	0.375	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34393911,G,G&fts=all">p.R44C</a>
FAM209B	Missense_Mutation	p.E118K	G	G		10	SNP	20	55111330	55111330	290	0.303448275862069	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM209B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,55111330,G,G&fts=all">p.E118K</a>
FRRS1L	Missense_Mutation	p.S201L	G	G		10	SNP	9	111909344	111909344	169	0.686390532544379	NA	NA	NA				DOMON. {ECO:0000255|PROSITE- ProRule:PRU00246}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRRS1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,111909344,G,G&fts=all">p.S201L</a>
KAT7	Missense_Mutation	p.R259Q	G	G		10	SNP	17	47888860	47888860	266	0.0225563909774436	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47888860,G,G&fts=all">p.R259Q</a>
NPAP1	Missense_Mutation	p.L795F	C	C		10	SNP	15	24923397	24923397	281	0.330960854092527	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,24923397,C,C&fts=all">p.L795F</a>
NXPE3	Missense_Mutation	p.S184F	C	C		10	SNP	3	101520536	101520536	122	0.360655737704918	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101520536,C,C&fts=all">p.S184F</a>
PRRC2C	Missense_Mutation	p.P811L	C	C		10	SNP	1	171506546	171506546	35	0.285714285714286	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171506546,C,C&fts=all">p.P811L</a>
RP11-35J10.5	lincRNA		C	C		10	SNP	11	7723347	7723347	55	0.509090909090909	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-35J10.5&recr=Open">Click here</a>	
RP11-468E2.4	Missense_Mutation	p.S352L	C	C	rs543452129	10	SNP	14	24626750	24626750	334	0.359281437125749	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-468E2.4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24626750,C,C&fts=all">p.S352L</a>
RP11-731F5.1	lincRNA		C	C		10	SNP	14	106067431	106067431	35	0.314285714285714	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-731F5.1&recr=Open">Click here</a>	
SLC52A1	Missense_Mutation	p.C126F	C	C		10	SNP	17	4937407	4937407	214	0.0233644859813084	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC52A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4937407,C,C&fts=all">p.C126F</a>
SLC52A3	Missense_Mutation	p.G364R	C	C		10	SNP	20	742452	742452	81	0.333333333333333	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC52A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,742452,C,C&fts=all">p.G364R</a>
TBATA	Missense_Mutation	p.G181R	C	C		10	SNP	10	72537058	72537058	97	0.381443298969072	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBATA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72537058,C,C&fts=all">p.G181R</a>
TENM3	Nonsense_Mutation	p.R1576*	C	C		10	SNP	4	183676246	183676246	167	0.37125748502994	NA	NA	NA		p.R1576*(1)				MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183676246,C,C&fts=all">p.R1576*</a>
TENM4	Missense_Mutation	p.R925C	G	G	rs374688338	10	SNP	11	78449599	78449599	83	0.397590361445783	NA	NA	NA						MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,78449599,G,G&fts=all">p.R925C</a>
A4GNT	Silent	p.Q295Q	C	C		11	Filtered Calls	3	137843244	137843244	190	0.4	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A4GNT&recr=Open">Click here</a>	
ABCA4	Silent	p.L738L	C	C	rs200277065	11	Filtered Calls	1	94522325	94522325	32	0.28125	NA	NA	NA			147			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	
ABCB1	Silent	p.I896I	G	G	rs532094830	11	Filtered Calls	7	87150190	87150190	217	0.387096774193548	NA	NA	NA			111	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB1&recr=Open">Click here</a>	
ABCB11	Silent	p.A1232A	G	G		11	Filtered Calls	2	169781236	169781236	289	0.401384083044983	NA	NA	NA			57	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	
ABCC3	Silent	p.R391R	G	G		11	Filtered Calls	17	48741216	48741216	106	0.367924528301887	NA	NA	NA			33	ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC3&recr=Open">Click here</a>	
ABCE1	Intron		C	C		11	Filtered Calls	4	146026747	146026747	278	0.388489208633094	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCE1&recr=Open">Click here</a>	
AC007040.11	5'UTR		G	G		11	Filtered Calls	2	71221888	71221888	21	0.476190476190476	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC007040.11&recr=Open">Click here</a>	
ACACB	Intron		C	C		11	Filtered Calls	12	109703188	109703188	35	0.457142857142857	NA	NA	NA			95			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACACB&recr=Open">Click here</a>	
ADAMTS12	Intron		G	G		11	Filtered Calls	5	33596170	33596170	230	0.343478260869565	NA	NA	NA			216			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS12&recr=Open">Click here</a>	
ADAMTS19	Intron		-	-	rs371218691	11	Filtered Calls	5	129015422	129015423	134	0.343283582089552	NA	NA	NA			91			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS19&recr=Open">Click here</a>	
ADAMTS6	Intron		G	G		11	Filtered Calls	5	64756172	64756172	136	0.352941176470588	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS6&recr=Open">Click here</a>	
AK5	Silent	p.L98L	C	C		11	Filtered Calls	1	77759524	77759524	272	0.341911764705882	NA	NA	NA			40			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK5&recr=Open">Click here</a>	
AKAP11	Intron		C	C		11	Filtered Calls	13	42882579	42882579	270	0.359259259259259	NA	NA	NA			56			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP11&recr=Open">Click here</a>	
AKR1C2	Silent	p.L113L	G	G		11	Filtered Calls	10	5042772	5042772	314	0.36624203821656	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1C2&recr=Open">Click here</a>	
ALK	Silent	p.K313K	C	C		11	Filtered Calls	2	29917729	29917729	193	0.378238341968912	NA	NA	NA			340	MAM 1. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALK&recr=Open">Click here</a>	
ANGPTL5	Silent	p.V160V	G	G		11	Filtered Calls	11	101773412	101773412	312	0.330128205128205	NA	NA	NA			29	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL5&recr=Open">Click here</a>	
ANK2	Silent	p.K283K	G	G		11	Filtered Calls	4	114163323	114163323	177	0.310734463276836	NA	NA	NA			248			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK2&recr=Open">Click here</a>	
AP2A1	Intron		C	C		11	Filtered Calls	19	50305408	50305408	15	0.6	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP2A1&recr=Open">Click here</a>	
APOBEC1	Silent	p.R154R	C	C		11	Filtered Calls	12	7803718	7803718	146	0.417808219178082	NA	NA	NA		p.R154S(1)	17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOBEC1&recr=Open">Click here</a>	
ARHGAP22	Silent	p.F216F	G	G		11	Filtered Calls	10	49667756	49667756	447	0.384787472035794	NA	NA	NA			18	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP22&recr=Open">Click here</a>	
ARHGEF38	IGR		A	A		11	Filtered Calls	4	106604418	106604418	82	0.463414634146341	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF38&recr=Open">Click here</a>	
ASIC2	Silent	p.A351A	C	C	rs544368158	11	Filtered Calls	17	31351022	31351022	263	0.357414448669202	NA	NA	NA		p.A402A(2)|p.A351A(2)	NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC2&recr=Open">Click here</a>	
ASTN2	Intron		C	C		11	Filtered Calls	9	119903627	119903627	48	0.729166666666667	NA	NA	NA			102			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	
ATP11A	Silent	p.R527R	G	G		11	Filtered Calls	13	113488924	113488924	458	0.320960698689956	NA	NA	NA			51			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP11A&recr=Open">Click here</a>	
ATP8B4	Silent	p.L1159L	C	C		11	Filtered Calls	15	50152493	50152493	290	0.33448275862069	NA	NA	NA			73			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	
BANF2	Intron		C	C		11	Filtered Calls	20	17705803	17705803	156	0.378205128205128	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BANF2&recr=Open">Click here</a>	
BDNF	Silent	p.L43L	G	G		11	Filtered Calls	11	27679985	27679985	269	0.37546468401487	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BDNF&recr=Open">Click here</a>	
BIRC6	Silent	p.K551K	G	G		11	Filtered Calls	2	32640012	32640012	102	0.303921568627451	NA	NA	NA			172			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC6&recr=Open">Click here</a>	
BPIFB1	Silent	p.R63R	G	G		11	Filtered Calls	20	31876620	31876620	75	0.36	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB1&recr=Open">Click here</a>	
BRSK1	Silent	p.I88I	C	C	rs372144256	11	Filtered Calls	19	55798614	55798614	281	0.380782918149466	NA	NA	NA			48	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRSK1&recr=Open">Click here</a>	
BZRAP1	Silent	p.I840I	G	G		11	Filtered Calls	17	56389482	56389482	80	0.425	NA	NA	NA			54	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BZRAP1&recr=Open">Click here</a>	
C11orf30	Silent	p.S1124S	C	C		11	Filtered Calls	11	76257212	76257212	257	0.396887159533074	NA	NA	NA			60			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf30&recr=Open">Click here</a>	
C1orf168	Silent	p.K369K	C	C		11	Filtered Calls	1	57221592	57221592	164	0.420731707317073	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf168&recr=Open">Click here</a>	
C1orf173	Silent	p.Q1239Q	C	C		11	Filtered Calls	1	75037677	75037677	73	0.328767123287671	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	
C4orf17	Intron		C	C		11	Filtered Calls	4	100460308	100460308	483	0.385093167701863	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C4orf17&recr=Open">Click here</a>	
CACNA1S	Silent	p.G583G	C	C		11	Filtered Calls	1	201046126	201046126	278	0.226618705035971	NA	NA	NA			102			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	
CACNG3	Silent	p.S213S	G	G		11	Filtered Calls	16	24372875	24372875	197	0.365482233502538	NA	NA	NA			40			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG3&recr=Open">Click here</a>	
CACNG6	Silent	p.F169F	C	C		11	Filtered Calls	19	54502988	54502988	316	0.329113924050633	NA	NA	NA		p.F169L(1)	15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG6&recr=Open">Click here</a>	
CAGE1	Silent	p.K496K	C	C		11	Filtered Calls	6	7373564	7373564	136	0.242647058823529	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAGE1&recr=Open">Click here</a>	
CAMTA1	Silent	p.V153V	C	C		11	Filtered Calls	1	7527910	7527910	207	0.603864734299517	NA	NA	NA			85			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMTA1&recr=Open">Click here</a>	
CAPZA3	Silent	p.I109I	C	C		11	Filtered Calls	12	18891529	18891529	177	0.384180790960452	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPZA3&recr=Open">Click here</a>	
CASKIN1	Silent	p.S1168S	G	G		11	Filtered Calls	16	2229865	2229865	36	0.25	NA	NA	NA			28	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASKIN1&recr=Open">Click here</a>	
CASR	Silent	p.F725F	C	C		11	Filtered Calls	3	122002976	122002976	84	0.416666666666667	NA	NA	NA			84			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASR&recr=Open">Click here</a>	
CATSPER2	Silent	p.L220L	G	G	rs368502475	11	Filtered Calls	15	43931898	43931898	497	0.374245472837022	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPER2&recr=Open">Click here</a>	
CC2D1A	Intron		C	C		11	Filtered Calls	19	14034355	14034355	95	0.221052631578947	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CC2D1A&recr=Open">Click here</a>	
CCDC68	Intron		G	G		11	Filtered Calls	18	52586490	52586490	204	0.357843137254902	NA	NA	NA			14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC68&recr=Open">Click here</a>	
CEACAM5	Intron		C	C	rs565862351	11	Filtered Calls	19	42213969	42213969	635	0.324409448818898	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM5&recr=Open">Click here</a>	
CENPE	Silent	p.F280F	G	G		11	Filtered Calls	4	104104042	104104042	213	0.352112676056338	NA	NA	NA			101	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPE&recr=Open">Click here</a>	
CGNL1	Silent	p.S297S	C	C		11	Filtered Calls	15	57731088	57731088	51	0.392156862745098	NA	NA	NA			60	Head.|Poly-Ser.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGNL1&recr=Open">Click here</a>	
CHRM2	Silent	p.L160L	C	C		11	Filtered Calls	7	136700092	136700092	288	0.427083333333333	NA	NA	NA			68			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM2&recr=Open">Click here</a>	
CHRM3	Silent	p.I84I	C	C		11	Filtered Calls	1	240071003	240071003	211	0.293838862559242	NA	NA	NA			51			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM3&recr=Open">Click here</a>	
CLEC4G	Silent	p.V88V	G	G		11	Filtered Calls	19	7795931	7795931	46	0.130434782608696	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4G&recr=Open">Click here</a>	
CLIP2	Intron		C	C		11	Filtered Calls	7	73778578	73778578	30	0.233333333333333	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIP2&recr=Open">Click here</a>	
CLSPN	Intron		G	G		11	Filtered Calls	1	36227678	36227678	163	0.337423312883436	NA	NA	NA			56			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSPN&recr=Open">Click here</a>	
CNOT2	Intron		T	T		11	Filtered Calls	12	70747606	70747606	209	0.334928229665072	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNOT2&recr=Open">Click here</a>	
CNR1	Silent	p.F180F	G	G		11	Filtered Calls	6	88854454	88854454	89	0.449438202247191	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNR1&recr=Open">Click here</a>	
COL9A2	Silent	p.G199G	C	C		11	Filtered Calls	1	40776798	40776798	100	0.28	NA	NA	NA			22	Triple-helical region 3 (COL3).		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A2&recr=Open">Click here</a>	
CSRP3	Silent	p.Q24Q	C	C		11	Filtered Calls	11	19213924	19213924	245	0.375510204081633	NA	NA	NA			10	LIM zinc-binding 1. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSRP3&recr=Open">Click here</a>	
CTBP2	Intron		G	G		11	Filtered Calls	10	126715669	126715669	104	0.423076923076923	NA	NA	NA			25			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTBP2&recr=Open">Click here</a>	
CYP4A11	Intron		C	C	rs369635654	11	Filtered Calls	1	47403659	47403659	151	0.43046357615894	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A11&recr=Open">Click here</a>	
DBP	IGR		C	C		11	Filtered Calls	19	49132238	49132238	90	0.355555555555556	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DBP&recr=Open">Click here</a>	
DBP	IGR		C	C		11	Filtered Calls	19	49132239	49132239	90	0.355555555555556	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DBP&recr=Open">Click here</a>	
DCP1B	IGR		G	G		11	Filtered Calls	12	2058479	2058479	101	0.376237623762376	NA	NA	NA			24			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCP1B&recr=Open">Click here</a>	
DDX39A	Intron		C	C		11	Filtered Calls	19	14519842	14519842	160	0.10625	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX39A&recr=Open">Click here</a>	
DHDH	Intron		C	C		11	Filtered Calls	19	49447675	49447675	149	0.0268456375838926	NA	NA	NA			9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHDH&recr=Open">Click here</a>	
DHX37	Intron		C	C	rs376389189	11	Filtered Calls	12	125434520	125434520	62	0.516129032258065	NA	NA	NA			65			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX37&recr=Open">Click here</a>	
DHX37	Silent	p.P814P	G	G		11	Filtered Calls	12	125434999	125434999	77	0.558441558441558	NA	NA	NA			65			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX37&recr=Open">Click here</a>	
DIP2A	Silent	p.F1553F	C	C		11	Filtered Calls	21	47987490	47987490	206	0.398058252427184	NA	NA	NA			43			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIP2A&recr=Open">Click here</a>	
DLG1	Silent	p.I616I	A	A		11	Filtered Calls	3	196812540	196812540	283	0.31095406360424	NA	NA	NA			26	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLG1&recr=Open">Click here</a>	
DNAH5	Silent	p.G100G	C	C	rs543407739	11	Filtered Calls	5	13923527	13923527	175	0.325714285714286	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH8	Intron		G	G	rs201672902	11	Filtered Calls	6	38697704	38697704	56	0.464285714285714	NA	NA	NA			260			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH9	Silent	p.L3948L	C	C		11	Filtered Calls	17	11827225	11827225	219	0.378995433789954	NA	NA	NA			290	AAA 6. {ECO:0000250}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAJC10	Silent	p.S354S	G	G	rs200295491	11	Filtered Calls	2	183605100	183605100	349	0.0143266475644699	NA	NA	NA			32	Trxb 2.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC10&recr=Open">Click here</a>	
DNMT1	Silent	p.A945A	G	G		11	Filtered Calls	19	10257038	10257038	63	0.142857142857143	NA	NA	NA			70			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMT1&recr=Open">Click here</a>	
DPYD	Silent	p.V812V	G	G		11	Filtered Calls	1	97700414	97700414	79	0.544303797468354	NA	NA	NA			83			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYD&recr=Open">Click here</a>	
DUSP27	Silent	p.E578E	G	G		11	Filtered Calls	1	167096102	167096102	97	0.56701030927835	NA	NA	NA			89			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	
DYRK2	3'UTR		G	G	rs557417303	11	Filtered Calls	12	68052500	68052500	374	0.0160427807486631	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYRK2&recr=Open">Click here</a>	
DZIP1	Silent	p.V84V	C	C		11	Filtered Calls	13	96293894	96293894	236	0.292372881355932	NA	NA	NA			38			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	
DZIP3	Intron		T	T		11	Filtered Calls	3	108363640	108363640	68	0.426470588235294	NA	NA	NA			45			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP3&recr=Open">Click here</a>	
EGR4	Silent	p.A322A	C	C		11	Filtered Calls	2	73519080	73519080	15	0.533333333333333	NA	NA	NA			11	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGR4&recr=Open">Click here</a>	
ENDOU	Silent	p.R211R	C	C		11	Filtered Calls	12	48110201	48110201	100	0.38	NA	NA	NA		p.N163fs*23(1)	14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENDOU&recr=Open">Click here</a>	
EPHA3	Silent	p.F667F	C	C		11	Filtered Calls	3	89468467	89468467	229	0.353711790393013	NA	NA	NA			139	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	
EPHA6	Silent	p.L351L	C	C		11	Filtered Calls	3	96706774	96706774	187	0.352941176470588	NA	NA	NA			101	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	
ERCC1	Intron		G	G		11	Filtered Calls	19	45912992	45912992	47	0.127659574468085	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC1&recr=Open">Click here</a>	
EXD2	Silent	p.V288V	C	C		11	Filtered Calls	14	69701563	69701563	138	0.420289855072464	NA	NA	NA			14			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXD2&recr=Open">Click here</a>	
F13B	Intron		G	G		11	Filtered Calls	1	197026602	197026602	154	0.324675324675325	NA	NA	NA			66			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13B&recr=Open">Click here</a>	
F2RL3	Silent	p.F296F	C	C		11	Filtered Calls	19	17001162	17001162	15	0.466666666666667	NA	NA	NA			7			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F2RL3&recr=Open">Click here</a>	
FAM181A	Silent	p.L68L	G	G		11	Filtered Calls	14	94394835	94394835	44	0.454545454545455	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM181A&recr=Open">Click here</a>	
FAT1	5'Flank		C	C	rs369440829	11	Filtered Calls	4	187518154	187518154	210	0.019047619047619	NA	NA	NA			228			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	
FBN1	Intron		G	G		11	Filtered Calls	15	48807573	48807573	124	0.32258064516129	NA	NA	NA			139			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN1&recr=Open">Click here</a>	
FBXO4	Intron		T	T	rs201857049	11	Filtered Calls	5	41934223	41934223	78	0.307692307692308	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO4&recr=Open">Click here</a>	
FCRL4	Silent	p.G317G	C	C	rs376872127	11	Filtered Calls	1	157556142	157556142	234	0.239316239316239	NA	NA	NA			40	Ig-like C2-type 4.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL4&recr=Open">Click here</a>	
FGB	Intron		C	C		11	Filtered Calls	4	155487766	155487766	260	0.334615384615385	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGB&recr=Open">Click here</a>	
FICD	3'UTR		C	C		11	Filtered Calls	12	108913263	108913263	31	0.419354838709677	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FICD&recr=Open">Click here</a>	
FLG	Silent	p.R3892R	C	C		11	Filtered Calls	1	152275686	152275686	225	0.28	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	
FRMPD3	Silent	p.I483I	C	C		11	Filtered Calls	X	106819598	106819598	216	0.805555555555556	NA	NA	NA			28	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	
FSD1	Intron		G	G		11	Filtered Calls	19	4318953	4318953	65	0.169230769230769	NA	NA	NA			21			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSD1&recr=Open">Click here</a>	
FUS	Intron		T	T		11	Filtered Calls	16	31195522	31195522	260	0.388461538461538	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUS&recr=Open">Click here</a>	
FUT7	Silent	p.T238T	C	C		11	Filtered Calls	9	139925477	139925477	235	0.634042553191489	NA	NA	NA		p.T238T(1)	8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUT7&recr=Open">Click here</a>	
GABRA2	Intron		G	G		11	Filtered Calls	4	46305633	46305633	91	0.307692307692308	NA	NA	NA			56			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA2&recr=Open">Click here</a>	
GABRG3	Silent	p.I144I	C	C		11	Filtered Calls	15	27572117	27572117	110	0.427272727272727	NA	NA	NA			42			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG3&recr=Open">Click here</a>	
GBA3	RNA		T	T		11	Filtered Calls	4	22729511	22729511	385	0.376623376623377	NA	NA	NA			33			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBA3&recr=Open">Click here</a>	
GCN1L1	Silent	p.I2444I	G	G		11	Filtered Calls	12	120569812	120569812	78	0.243589743589744	NA	NA	NA			94			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	
GDF9	Silent	p.Y443Y	G	G	rs191882278	11	Filtered Calls	5	132197317	132197317	391	0.0153452685421995	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF9&recr=Open">Click here</a>	
GFRA3	Silent	p.R94R	C	C		11	Filtered Calls	5	137600047	137600047	129	0.372093023255814	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRA3&recr=Open">Click here</a>	
GLTSCR2	Intron		C	C		11	Filtered Calls	19	48250213	48250213	183	0.475409836065574	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLTSCR2&recr=Open">Click here</a>	
GNG4	Silent	p.A37A	T	T		11	Filtered Calls	1	235715526	235715526	305	0.245901639344262	NA	NA	NA			8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNG4&recr=Open">Click here</a>	
GPC2	Silent	p.T220T	G	G		11	Filtered Calls	7	99772377	99772377	91	0.373626373626374	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC2&recr=Open">Click here</a>	
GPR98	Silent	p.P352P	G	G	rs115239207	11	Filtered Calls	5	89923411	89923411	435	0.35632183908046	NA	NA	NA			269	Calx-beta 3. {ECO:0000305|PubMed:11606593}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GRIN2B	Silent	p.F273F	G	G		11	Filtered Calls	12	13906442	13906442	81	0.518518518518518	NA	NA	NA			143			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	
GRM3	Silent	p.V673V	C	C		11	Filtered Calls	7	86468849	86468849	182	0.395604395604396	NA	NA	NA			109			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM3&recr=Open">Click here</a>	
GRN	Silent	p.G95G	C	C	rs370619392	11	Filtered Calls	17	42427055	42427055	63	0.206349206349206	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRN&recr=Open">Click here</a>	
GTF2IRD1	Silent	p.A143A	C	C		11	Filtered Calls	7	73932476	73932476	17	0.411764705882353	NA	NA	NA			49			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF2IRD1&recr=Open">Click here</a>	
GTF3C3	Intron		C	C		11	Filtered Calls	2	197653893	197653893	94	0.340425531914894	NA	NA	NA			33			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C3&recr=Open">Click here</a>	
GZMK	Intron		C	C		11	Filtered Calls	5	54327181	54327181	127	0.417322834645669	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GZMK&recr=Open">Click here</a>	
HHIP	Silent	p.G471G	G	G		11	Filtered Calls	4	145633213	145633213	327	0.342507645259939	NA	NA	NA		p.G471G(1)	33			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHIP&recr=Open">Click here</a>	
HIST1H2AA	Silent	p.G5G	C	C		11	Filtered Calls	6	25726741	25726741	374	0.582887700534759	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H2AA&recr=Open">Click here</a>	
HIVEP3	Silent	p.L1240L	G	G		11	Filtered Calls	1	42046751	42046751	89	0.404494382022472	NA	NA	NA			85			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP3&recr=Open">Click here</a>	
HMG20A	Intron		C	C		11	Filtered Calls	15	77769892	77769892	107	0.345794392523364	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMG20A&recr=Open">Click here</a>	
HMGCLL1	Intron		C	C		11	Filtered Calls	6	55441933	55441933	45	0.222222222222222	NA	NA	NA			31			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCLL1&recr=Open">Click here</a>	
HNRNPUL1	Intron		C	C		11	Filtered Calls	19	41782055	41782055	366	0.286885245901639	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPUL1&recr=Open">Click here</a>	
HS3ST2	Silent	p.R205R	G	G		11	Filtered Calls	16	22926394	22926394	303	0.372937293729373	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST2&recr=Open">Click here</a>	
HSD3B2	Silent	p.P155P	G	G	rs114527791	11	Filtered Calls	1	119964589	119964589	250	0.416	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD3B2&recr=Open">Click here</a>	
IFNA5	Silent	p.I47I	G	G	rs375253471	11	Filtered Calls	9	21305115	21305115	199	0.64321608040201	NA	NA	NA		p.I47I(1)	7			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA5&recr=Open">Click here</a>	
IGHJ6	RNA		G	G		11	Filtered Calls	14	106330482	106330482	16	0.5625	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHJ6&recr=Open">Click here</a>	
IGHV1-46	RNA		G	G		11	Filtered Calls	14	106967071	106967071	715	0.00979020979020979	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV1-46&recr=Open">Click here</a>	
IGHV1OR21-1	RNA		C	C		11	Filtered Calls	21	10862823	10862823	426	0.0962441314553991	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV1OR21-1&recr=Open">Click here</a>	
IGHV3-20	RNA		G	G	rs185668244	11	Filtered Calls	14	106667791	106667791	311	0.382636655948553	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-20&recr=Open">Click here</a>	
IGLV3-22	RNA		G	G		11	Filtered Calls	22	23047185	23047185	67	0.238805970149254	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV3-22&recr=Open">Click here</a>	
IL19	Silent	p.A83A	G	G		11	Filtered Calls	1	207013233	207013233	1264	0.00632911392405063	NA	NA	NA			7			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL19&recr=Open">Click here</a>	
IL1RN	5'UTR		G	G	rs2232353	11	Filtered Calls	2	113885270	113885270	151	0.350993377483444	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RN&recr=Open">Click here</a>	
IL20	Silent	p.V34V	G	G		11	Filtered Calls	1	207039299	207039299	278	0.287769784172662	NA	NA	NA			9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL20&recr=Open">Click here</a>	
ILDR1	Silent	p.L84L	C	C		11	Filtered Calls	3	121724218	121724218	102	0.333333333333333	NA	NA	NA			25	Ig-like V-type.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR1&recr=Open">Click here</a>	
IQCB1	Intron		-	-		11	Filtered Calls	3	121514464	121514465	84	0.285714285714286	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCB1&recr=Open">Click here</a>	
JHDM1D	Intron		G	G		11	Filtered Calls	7	139819026	139819026	160	0.40625	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JHDM1D&recr=Open">Click here</a>	
KALRN	Silent	p.K46K	G	G		11	Filtered Calls	3	124397130	124397130	149	0.315436241610738	NA	NA	NA			83	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	
KCNJ16	Silent	p.S84S	G	G		11	Filtered Calls	17	68128480	68128480	326	0.0153374233128834	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ16&recr=Open">Click here</a>	
KCNK18	Intron		G	G		11	Filtered Calls	10	118960810	118960810	132	0.356060606060606	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK18&recr=Open">Click here</a>	
KIAA0922	Silent	p.S1387S	C	C		11	Filtered Calls	4	154548793	154548793	130	0.361538461538462	NA	NA	NA			63			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0922&recr=Open">Click here</a>	
KIAA1217	Intron		C	C		11	Filtered Calls	10	24833126	24833126	119	0.327731092436975	NA	NA	NA			70			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KMT2C	Silent	p.L602L	A	A	rs78466939	11	Filtered Calls	7	151946968	151946968	262	0.0190839694656489	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	
KMT2D	5'Flank		G	G		11	Filtered Calls	12	49433268	49433268	37	0.378378378378378	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	
KMT2D	5'Flank		G	G		11	Filtered Calls	12	49433269	49433269	35	0.371428571428571	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	
KNSTRN	Intron		C	C		11	Filtered Calls	15	40679351	40679351	56	0.410714285714286	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KNSTRN&recr=Open">Click here</a>	
KRT15	Intron		C	C		11	Filtered Calls	17	39674570	39674570	106	0.386792452830189	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT15&recr=Open">Click here</a>	
KRT9	Silent	p.T401T	C	C		11	Filtered Calls	17	39724605	39724605	164	0.402439024390244	NA	NA	NA			25	Coil 2.|Rod.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT9&recr=Open">Click here</a>	
LAMA1	Intron		C	C		11	Filtered Calls	18	6950776	6950776	136	0.397058823529412	NA	NA	NA		p.?(1)	205			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA1&recr=Open">Click here</a>	
LEPR	3'UTR		G	G		11	Filtered Calls	1	66102706	66102706	140	0.421428571428571	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPR&recr=Open">Click here</a>	
LGMN	Silent	p.I66I	G	G	rs140303947	11	Filtered Calls	14	93185130	93185130	393	0.363867684478371	NA	NA	NA		p.I66I(1)	18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGMN&recr=Open">Click here</a>	
LILRB1	Intron		C	C		11	Filtered Calls	19	55143911	55143911	195	0.471794871794872	NA	NA	NA			74			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB1&recr=Open">Click here</a>	
LIPH	Silent	p.F25F	G	G		11	Filtered Calls	3	185252895	185252895	310	0.383870967741935	NA	NA	NA			20			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPH&recr=Open">Click here</a>	
LMNA	Intron		C	C		11	Filtered Calls	1	156104186	156104186	120	0.291666666666667	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMNA&recr=Open">Click here</a>	
LRBA	Silent	p.F2273F	G	G	rs370252876	11	Filtered Calls	4	151357978	151357978	131	0.442748091603053	NA	NA	NA			91	BEACH. {ECO:0000255|PROSITE- ProRule:PRU00026}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRBA&recr=Open">Click here</a>	
LRRIQ3	Silent	p.L461L	C	C		11	Filtered Calls	1	74507232	74507232	356	0.339887640449438	NA	NA	NA			73			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ3&recr=Open">Click here</a>	
MAP3K1	Silent	p.T1267T	T	T		11	Filtered Calls	5	56179488	56179488	356	0.370786516853933	NA	NA	NA			57	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K1&recr=Open">Click here</a>	
MAPK4	Silent	p.S202S	C	C		11	Filtered Calls	18	48241508	48241508	179	0.307262569832402	NA	NA	NA			8	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK4&recr=Open">Click here</a>	
MAPK8IP2	Silent	p.F310F	C	C	rs555362115	11	Filtered Calls	22	51043455	51043455	140	0.407142857142857	NA	NA	NA			7	Necessary for interaction with FGF13.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP2&recr=Open">Click here</a>	
MARC1	Intron		C	C		11	Filtered Calls	1	220971207	220971207	289	0.238754325259516	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARC1&recr=Open">Click here</a>	
MARC2	Silent	p.V335V	G	G		11	Filtered Calls	1	220955240	220955240	693	0.0101010101010101	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARC2&recr=Open">Click here</a>	
MARVELD3	Silent	p.S160S	G	G	rs149016402	11	Filtered Calls	16	71663282	71663282	174	0.0229885057471264	NA	NA	NA			17	Pro-rich.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARVELD3&recr=Open">Click here</a>	
MEGF11	Silent	p.G323G	C	C		11	Filtered Calls	15	66257389	66257389	27	0.407407407407407	NA	NA	NA			19	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF11&recr=Open">Click here</a>	
MEGF8	Silent	p.A1276A	G	G		11	Filtered Calls	19	42858757	42858757	983	0.0081383519837233	NA	NA	NA			50	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF8&recr=Open">Click here</a>	
MKRN3	Intron		G	G		11	Filtered Calls	15	23811576	23811576	59	0.322033898305085	NA	NA	NA			61			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN3&recr=Open">Click here</a>	
MMP1	Silent	p.G48G	C	C		11	Filtered Calls	11	102668193	102668193	190	0.321052631578947	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP1&recr=Open">Click here</a>	
MMP12	RNA		G	G		11	Filtered Calls	11	102733914	102733914	257	0.365758754863813	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP12&recr=Open">Click here</a>	
MMP9	Silent	p.V8V	C	C		11	Filtered Calls	20	44637589	44637589	90	0.3	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP9&recr=Open">Click here</a>	
MON1B	Silent	p.F251F	C	C		11	Filtered Calls	16	77228836	77228836	144	0.368055555555556	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MON1B&recr=Open">Click here</a>	
MPPED1	Silent	p.A13A	G	G	rs568929744	11	Filtered Calls	22	43821030	43821030	19	0.263157894736842	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPPED1&recr=Open">Click here</a>	
MSRB1	Silent	p.Q91Q	C	C		11	Filtered Calls	16	1990825	1990825	90	0.277777777777778	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSRB1&recr=Open">Click here</a>	
MUC16	Intron		G	G		11	Filtered Calls	19	9024205	9024205	31	0.32258064516129	NA	NA	NA			590			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUTYH	Intron		T	T		11	Filtered Calls	1	45797716	45797716	153	0.352941176470588	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUTYH&recr=Open">Click here</a>	
MYH1	Silent	p.L1319L	C	C		11	Filtered Calls	17	10402318	10402318	276	0.38768115942029	NA	NA	NA			176			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH4	Silent	p.F543F	G	G		11	Filtered Calls	17	10361005	10361005	238	0.294117647058824	NA	NA	NA			149	Myosin motor.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	
MYO1F	Silent	p.Q533Q	C	C		11	Filtered Calls	19	8606801	8606801	115	0.547826086956522	NA	NA	NA			42	Myosin motor.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	
MYOM2	Intron		C	C		11	Filtered Calls	8	2064081	2064081	90	0.377777777777778	NA	NA	NA			104			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	
NAGLU	Silent	p.S278S	C	C		11	Filtered Calls	17	40693037	40693037	523	0.395793499043977	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAGLU&recr=Open">Click here</a>	
NBEA	Intron		C	C		11	Filtered Calls	13	35735877	35735877	34	0.5	NA	NA	NA			108			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEA&recr=Open">Click here</a>	
NEB	Silent	p.E6293E	C	C		11	Filtered Calls	2	152419137	152419137	67	0.283582089552239	NA	NA	NA			301			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NEBL	Silent	p.V166V	C	C		11	Filtered Calls	10	21101729	21101729	152	0.355263157894737	NA	NA	NA			70			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEBL&recr=Open">Click here</a>	
NLGN3	Silent	p.G375G	C	C		11	Filtered Calls	X	70387072	70387072	68	0.823529411764706	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN3&recr=Open">Click here</a>	
NME7	Intron		G	G		11	Filtered Calls	1	169279326	169279326	208	0.269230769230769	NA	NA	NA			16			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NME7&recr=Open">Click here</a>	
NPAS2	Intron		C	C		11	Filtered Calls	2	101591909	101591909	322	0.397515527950311	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS2&recr=Open">Click here</a>	
NSD1	Intron		C	C		11	Filtered Calls	5	176562509	176562509	279	0.344086021505376	NA	NA	NA			96			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSD1&recr=Open">Click here</a>	
NT5M	Silent	p.K91K	G	G	rs199941205	11	Filtered Calls	17	17209862	17209862	560	0.366071428571429	NA	NA	NA			4			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5M&recr=Open">Click here</a>	
NTN4	Intron		G	G		11	Filtered Calls	12	96181256	96181256	127	0.409448818897638	NA	NA	NA			25			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTN4&recr=Open">Click here</a>	
OBSCN	Silent	p.D6923D	C	C		11	Filtered Calls	1	228529179	228529179	100	0.2	NA	NA	NA			223			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OGDH	Silent	p.E792E	G	G		11	Filtered Calls	7	44737820	44737820	286	0.356643356643357	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDH&recr=Open">Click here</a>	
OR10X1	Silent	p.T73T	G	G		11	Filtered Calls	1	158549471	158549471	192	0.255208333333333	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10X1&recr=Open">Click here</a>	
OR12D3	Silent	p.*317*	C	C		11	Filtered Calls	6	29342114	29342114	337	0.525222551928783	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR12D3&recr=Open">Click here</a>	
OR4D9	Silent	p.F251F	C	C		11	Filtered Calls	11	59283138	59283138	504	0.412698412698413	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4D9&recr=Open">Click here</a>	
OR52E4	Silent	p.I137I	C	C		11	Filtered Calls	11	5905933	5905933	242	0.363636363636364	NA	NA	NA			30			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52E4&recr=Open">Click here</a>	
OR52E6	Silent	p.I273I	G	G		11	Filtered Calls	11	5862309	5862309	159	0.459119496855346	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52E6&recr=Open">Click here</a>	
OR5V1	Silent	p.L114L	G	G		11	Filtered Calls	6	29323633	29323633	240	0.554166666666667	NA	NA	NA			25			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5V1&recr=Open">Click here</a>	
OSGIN1	Silent	p.P330P	C	C		11	Filtered Calls	16	83999168	83999168	83	0.265060240963855	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSGIN1&recr=Open">Click here</a>	
OTOA	Silent	p.A628A	C	C		11	Filtered Calls	16	21737847	21737847	316	0.411392405063291	NA	NA	NA			46			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOA&recr=Open">Click here</a>	
OTOP1	Silent	p.K303K	C	C		11	Filtered Calls	4	4199652	4199652	156	0.423076923076923	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP1&recr=Open">Click here</a>	
OXCT2	Silent	p.I495I	G	G		11	Filtered Calls	1	40235443	40235443	80	0.45	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXCT2&recr=Open">Click here</a>	
PAK7	Silent	p.Q293Q	C	C		11	Filtered Calls	20	9560903	9560903	354	0.403954802259887	NA	NA	NA			81	Linker.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	
PCDHB2	Silent	p.Q195Q	G	G		11	Filtered Calls	5	140474959	140474959	71	0.309859154929577	NA	NA	NA			71	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB2&recr=Open">Click here</a>	
PCSK9	Intron		C	C	rs375695759	11	Filtered Calls	1	55518313	55518313	91	0.307692307692308	NA	NA	NA			32			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK9&recr=Open">Click here</a>	
PDCD11	Intron		C	C		11	Filtered Calls	10	105165737	105165737	229	0.266375545851528	NA	NA	NA			64			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD11&recr=Open">Click here</a>	
PDE6C	Silent	p.K38K	G	G		11	Filtered Calls	10	95372596	95372596	204	0.348039215686274	NA	NA	NA			42			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6C&recr=Open">Click here</a>	
PDGFRA	Intron		C	C		11	Filtered Calls	4	55155170	55155170	82	0.451219512195122	NA	NA	NA			967			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRA&recr=Open">Click here</a>	
PGLYRP3	Silent	p.T108T	G	G		11	Filtered Calls	1	153277475	153277475	246	0.268292682926829	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGLYRP3&recr=Open">Click here</a>	
PHLDB2	Intron		G	G		11	Filtered Calls	3	111671442	111671442	234	0.354700854700855	NA	NA	NA			55			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB2&recr=Open">Click here</a>	
PKHD1L1	Silent	p.F239F	C	C		11	Filtered Calls	8	110402700	110402700	18	0.5	NA	NA	NA			263	IPT/TIG 2.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Intron		C	C		11	Filtered Calls	8	110442274	110442274	49	0.469387755102041	NA	NA	NA			263			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKP1	Silent	p.K364K	G	G		11	Filtered Calls	1	201287783	201287783	133	0.285714285714286	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP1&recr=Open">Click here</a>	
PLA2G4F	Silent	p.F763F	G	G		11	Filtered Calls	15	42434766	42434766	146	0.356164383561644	NA	NA	NA			32	PLA2c. {ECO:0000255|PROSITE- ProRule:PRU00555}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G4F&recr=Open">Click here</a>	
PLEKHG2	Silent	p.L618L	C	C		11	Filtered Calls	19	39913548	39913548	92	0.402173913043478	NA	NA	NA			40			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG2&recr=Open">Click here</a>	
PLEKHG5	Silent	p.F74F	G	G		11	Filtered Calls	1	6537641	6537641	133	0.639097744360902	NA	NA	NA			1			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG5&recr=Open">Click here</a>	
PLEKHH1	Silent	p.S162S	C	C		11	Filtered Calls	14	68028733	68028733	107	0.355140186915888	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHH1&recr=Open">Click here</a>	
PLIN4	Silent	p.G1024G	C	C		11	Filtered Calls	19	4510858	4510858	78	0.192307692307692	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	
PMFBP1	Intron		G	G		11	Filtered Calls	16	72166900	72166900	545	0.0110091743119266	NA	NA	NA			45			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMFBP1&recr=Open">Click here</a>	
PNPO	Silent	p.E257E	G	G		11	Filtered Calls	17	46024133	46024133	184	0.5	NA	NA	NA			5			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPO&recr=Open">Click here</a>	
POLE2	Intron		A	A		11	Filtered Calls	14	50130113	50130113	131	0.366412213740458	NA	NA	NA			10			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLE2&recr=Open">Click here</a>	
POLR3D	Intron		G	G		11	Filtered Calls	8	22107897	22107897	35	0.342857142857143	NA	NA	NA			13			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3D&recr=Open">Click here</a>	
PPFIBP1	Silent	p.S812S	C	C		11	Filtered Calls	12	27841296	27841296	699	0.38483547925608	NA	NA	NA			32	SAM 3. {ECO:0000255|PROSITE- ProRule:PRU00184}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIBP1&recr=Open">Click here</a>	
PPP1R9B	5'UTR		G	G		11	Filtered Calls	17	48222497	48222497	80	0.4125	NA	NA	NA			8			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R9B&recr=Open">Click here</a>	
PPP2CA	Silent	p.T304T	G	G		11	Filtered Calls	5	133533481	133533481	127	0.385826771653543	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2CA&recr=Open">Click here</a>	
PPP2R1A	Silent	p.F170F	C	C		11	Filtered Calls	19	52715945	52715945	85	0.447058823529412	NA	NA	NA		p.R171fs*7(1)	135	PP2A subunit B binding.|Polyoma small and medium T antigens Binding.|SV40 small T antigen binding.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R1A&recr=Open">Click here</a>	
PPP3CB	Intron		G	G		11	Filtered Calls	10	75214256	75214256	184	0.402173913043478	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP3CB&recr=Open">Click here</a>	
PREX2	Silent	p.R965R	G	G		11	Filtered Calls	8	69020523	69020523	167	0.37125748502994	NA	NA	NA			178			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PROX1	Silent	p.Q306Q	G	G		11	Filtered Calls	1	214170796	214170796	201	0.253731343283582	NA	NA	NA			47			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	
PSMC4	Silent	p.F72F	T	T		11	Filtered Calls	19	40478356	40478356	121	0.31404958677686	NA	NA	NA			19			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMC4&recr=Open">Click here</a>	
PTCD3	IGR		T	T		11	Filtered Calls	2	86371761	86371761	349	0.415472779369628	NA	NA	NA			22			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCD3&recr=Open">Click here</a>	
PTPRN	Intron		G	G		11	Filtered Calls	2	220165656	220165656	188	0.356382978723404	NA	NA	NA			65			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
RAPSN	5'UTR		C	C		11	Filtered Calls	11	47470522	47470522	152	0.421052631578947	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAPSN&recr=Open">Click here</a>	
RASGRP1	Silent	p.S255S	G	G		11	Filtered Calls	15	38805068	38805068	76	0.394736842105263	NA	NA	NA			20	Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00168}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRP1&recr=Open">Click here</a>	
RBP3	Silent	p.A854A	G	G		11	Filtered Calls	10	48388316	48388316	32	0.375	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	
REEP4	Intron		G	G		11	Filtered Calls	8	21996200	21996200	167	0.383233532934132	NA	NA	NA			7			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REEP4&recr=Open">Click here</a>	
RHAG	Silent	p.Q273Q	C	C		11	Filtered Calls	6	49580236	49580236	165	0.272727272727273	NA	NA	NA			39			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHAG&recr=Open">Click here</a>	
ROS1	Intron		G	G		11	Filtered Calls	6	117647378	117647378	57	0.614035087719298	NA	NA	NA			162			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	
RP1	Silent	p.L1128L	C	C	rs138461381	11	Filtered Calls	8	55539826	55539826	194	0.288659793814433	NA	NA	NA		p.L1128L(1)	169			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	
RP11-321M21.3	Intron		C	C		11	Filtered Calls	18	73130761	73130761	357	0.288515406162465	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-321M21.3&recr=Open">Click here</a>	
RP11-64J4.2	RNA		C	C		11	Filtered Calls	17	3213760	3213760	162	0.432098765432099	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-64J4.2&recr=Open">Click here</a>	
RP4-576H24.4	Intron		G	G		11	Filtered Calls	20	1552427	1552427	151	0.450331125827815	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP4-576H24.4&recr=Open">Click here</a>	
RPE65	Silent	p.I98I	G	G	rs62642583|rs367983478	11	Filtered Calls	1	68910518	68910518	178	0.421348314606742	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPE65&recr=Open">Click here</a>	
RPS27L	Intron		-	-		11	Filtered Calls	15	63448523	63448524	10	0.4	NA	NA	NA			1			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS27L&recr=Open">Click here</a>	
SCP2	Intron		C	C		11	Filtered Calls	1	53407493	53407493	187	0.459893048128342	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCP2&recr=Open">Click here</a>	
SDPR	Intron		G	G		11	Filtered Calls	2	192711159	192711159	26	0.576923076923077	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDPR&recr=Open">Click here</a>	
SF3A1	Silent	p.S203S	G	G		11	Filtered Calls	22	30740964	30740964	304	0.417763157894737	NA	NA	NA			29			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3A1&recr=Open">Click here</a>	
SHROOM3	Silent	p.L412L	C	C		11	Filtered Calls	4	77660562	77660562	106	0.39622641509434	NA	NA	NA			60			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM3&recr=Open">Click here</a>	
SIGLEC1	Silent	p.L37L	G	G		11	Filtered Calls	20	3687294	3687294	11	0.454545454545455	NA	NA	NA			70	Ig-like V-type.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC1&recr=Open">Click here</a>	
SIGLEC9	Intron		G	G		11	Filtered Calls	19	51633348	51633348	123	0.430894308943089	NA	NA	NA			45			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC9&recr=Open">Click here</a>	
SLAMF8	Silent	p.F43F	C	C		11	Filtered Calls	1	159799744	159799744	566	0.540636042402827	NA	NA	NA			12			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLAMF8&recr=Open">Click here</a>	
SLC17A7	Intron		G	G		11	Filtered Calls	19	49934406	49934406	36	0.388888888888889	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A7&recr=Open">Click here</a>	
SLC29A3	Silent	p.L235L	C	C		11	Filtered Calls	10	73115930	73115930	129	0.302325581395349	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A3&recr=Open">Click here</a>	
SLC34A2	Silent	p.I446I	C	C	rs200795814	11	Filtered Calls	4	25676131	25676131	248	0.375	NA	NA	NA			41			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	
SLC44A5	Intron		G	G		11	Filtered Calls	1	75707758	75707758	267	0.397003745318352	NA	NA	NA			61			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A5&recr=Open">Click here</a>	
SLC5A1	Silent	p.S146S	C	C		11	Filtered Calls	22	32464548	32464548	127	0.377952755905512	NA	NA	NA			37			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A1&recr=Open">Click here</a>	
SLFN11	Silent	p.R156R	C	C		11	Filtered Calls	17	33690359	33690359	240	0.383333333333333	NA	NA	NA			50			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLFN11&recr=Open">Click here</a>	
SLIT3	Silent	p.Q257Q	C	C		11	Filtered Calls	5	168244327	168244327	117	0.358974358974359	NA	NA	NA			100	LRRCT 1.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25344651	25344651	214	0.350467289719626	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SORCS2	Silent	p.I573I	C	C	rs542238272	11	Filtered Calls	4	7705057	7705057	60	0.4	NA	NA	NA			42			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	
SPEN	Silent	p.I2622I	T	T		11	Filtered Calls	1	16260601	16260601	231	0.696969696969697	NA	NA	NA			149	RID.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEN&recr=Open">Click here</a>	
SPTBN2	Silent	p.I1244I	G	G		11	Filtered Calls	11	66466921	66466921	241	0.319502074688797	NA	NA	NA			74			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN2&recr=Open">Click here</a>	
SSTR2	Silent	p.I260I	C	C		11	Filtered Calls	17	71166238	71166238	272	0.330882352941176	NA	NA	NA			11			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSTR2&recr=Open">Click here</a>	
SV2B	Silent	p.V455V	G	G		11	Filtered Calls	15	91811827	91811827	193	0.352331606217617	NA	NA	NA			42			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SV2B&recr=Open">Click here</a>	
SYCP2L	Silent	p.V138V	T	T		11	Filtered Calls	6	10898321	10898321	283	0.286219081272085	NA	NA	NA			36			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP2L&recr=Open">Click here</a>	
TBCD	Intron		A	A		11	Filtered Calls	17	80788762	80788762	84	0.392857142857143	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBCD&recr=Open">Click here</a>	
TBL1XR1	Intron		G	G		11	Filtered Calls	3	176756091	176756091	50	0.32	NA	NA	NA			31			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBL1XR1&recr=Open">Click here</a>	
TGFB1I1	Intron		C	C		11	Filtered Calls	16	31488626	31488626	71	0.408450704225352	NA	NA	NA			9			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGFB1I1&recr=Open">Click here</a>	
THNSL1	Silent	p.V431V	G	G		11	Filtered Calls	10	25313445	25313445	284	0.426056338028169	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THNSL1&recr=Open">Click here</a>	
TIAM1	Silent	p.P776P	A	A		11	Filtered Calls	21	32582421	32582421	89	0.348314606741573	NA	NA	NA			115	RBD. {ECO:0000255|PROSITE- ProRule:PRU00262}.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAM1&recr=Open">Click here</a>	
TKTL2	Silent	p.L179L	G	G	rs143127371	11	Filtered Calls	4	164394350	164394350	170	0.352941176470588	NA	NA	NA			70			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TKTL2&recr=Open">Click here</a>	
TLX1	Silent	p.S316S	G	G		11	Filtered Calls	10	102896625	102896625	172	0.354651162790698	NA	NA	NA			2			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLX1&recr=Open">Click here</a>	
TMEM201	Silent	p.G379G	C	C		11	Filtered Calls	1	9662307	9662307	35	0.714285714285714	NA	NA	NA			4			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM201&recr=Open">Click here</a>	
TMEM225	Silent	p.I137I	G	G		11	Filtered Calls	11	123754834	123754834	85	0.682352941176471	NA	NA	NA			28			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM225&recr=Open">Click here</a>	
TPR	Silent	p.T833T	G	G		11	Filtered Calls	1	186320573	186320573	405	0.266666666666667	NA	NA	NA			123			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPR&recr=Open">Click here</a>	
TRA2B	Intron		A	A		11	Filtered Calls	3	185638886	185638886	213	0.352112676056338	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRA2B&recr=Open">Click here</a>	
TRAV1-2	RNA		G	G		11	Filtered Calls	14	22111699	22111699	368	0.342391304347826	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV1-2&recr=Open">Click here</a>	
TRAV4	RNA		C	C		11	Filtered Calls	14	22205179	22205179	105	0.323809523809524	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV4&recr=Open">Click here</a>	
TREML2	Intron		G	G		11	Filtered Calls	6	41162582	41162582	106	0.283018867924528	NA	NA	NA			18			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TREML2&recr=Open">Click here</a>	
TRIT1	Intron		C	C		11	Filtered Calls	1	40322938	40322938	42	0.404761904761905	NA	NA	NA			15			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIT1&recr=Open">Click here</a>	
TRPV1	Silent	p.F483F	G	G		11	Filtered Calls	17	3480976	3480976	26	0.423076923076923	NA	NA	NA			17			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV1&recr=Open">Click here</a>	
TTBK2	Intron		G	G		11	Filtered Calls	15	43093379	43093379	141	0.432624113475177	NA	NA	NA			43			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK2&recr=Open">Click here</a>	
TTBK2	Intron		G	G		11	Filtered Calls	15	43093941	43093941	195	0.297435897435897	NA	NA	NA			43			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK2&recr=Open">Click here</a>	
TTN	Silent	p.K21003K	C	C		11	Filtered Calls	2	179453443	179453443	187	0.374331550802139	NA	NA	NA			1448			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
UNC13A	Intron		G	G		11	Filtered Calls	19	17722667	17722667	103	0.233009708737864	NA	NA	NA			61			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	
USP53	Silent	p.R235R	C	C		11	Filtered Calls	4	120181691	120181691	194	0.417525773195876	NA	NA	NA			27			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP53&recr=Open">Click here</a>	
USP6	Silent	p.F328F	C	C		11	Filtered Calls	17	5041474	5041474	156	0.403846153846154	NA	NA	NA			34			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	
USP6	Silent	p.R1101R	G	G		11	Filtered Calls	17	5072136	5072136	381	0.409448818897638	NA	NA	NA			34	USP.		MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	
USP7	Silent	p.I1005I	G	G		11	Filtered Calls	16	8988912	8988912	556	0.431654676258993	NA	NA	NA			48			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP7&recr=Open">Click here</a>	
Unknown	IGR		A	A		11	Filtered Calls	3	132120026	132120026	49	0.428571428571429	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	19	19478831	19478831	27	0.518518518518518	NA	NA	NA			NA			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
VCAN	Intron		C	C		11	Filtered Calls	5	82817203	82817203	98	0.418367346938776	NA	NA	NA			190			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VPS8	Intron		C	C		11	Filtered Calls	3	184586725	184586725	39	0.461538461538462	NA	NA	NA			54			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS8&recr=Open">Click here</a>	
WDR49	3'UTR		C	C		11	Filtered Calls	3	167196764	167196764	85	0.317647058823529	NA	NA	NA			50			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR49&recr=Open">Click here</a>	
WDR65	Silent	p.S478S	C	C		11	Filtered Calls	1	43665066	43665066	400	0.33	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR65&recr=Open">Click here</a>	
ZNF257	Silent	p.T417T	C	C		11	Filtered Calls	19	22271803	22271803	65	0.476923076923077	NA	NA	NA			6			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF257&recr=Open">Click here</a>	
ZNF512B	Intron		C	C		11	Filtered Calls	20	62624794	62624794	195	0.266666666666667	NA	NA	NA			33			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF512B&recr=Open">Click here</a>	
ZNF786	Silent	p.L161L	G	G		11	Filtered Calls	7	148769383	148769383	33	0.424242424242424	NA	NA	NA			26			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF786&recr=Open">Click here</a>	
ZPLD1	5'UTR		G	G		11	Filtered Calls	3	102153995	102153995	204	0.397058823529412	NA	NA	NA			35			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZPLD1&recr=Open">Click here</a>	
ZRANB1	Silent	p.N162N	C	C		11	Filtered Calls	10	126631548	126631548	305	0.39672131147541	NA	NA	NA			23			MEL-IPI_Pat41-Tumor-SM-4DK22	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZRANB1&recr=Open">Click here</a>	
